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ADH    alcohol dehydrogenase  
ALDH   aldehyde dehydrogenase 
CFU    colony forming units 
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IARC   International Agency for Research on Cancer 
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ABSTRACT 
Heavy alcohol consumption is a well-known 
risk factor for upper digestive tract cancers. The 
exact mechanism responsible for this is still 
obscure, but it has been suggested to be related 
to toxic effects of ethanol’s first metabolite, 
acetaldehyde, which is a recognized animal 
carcinogen. Many microbes of the gastro-
intestinal tract can oxidize ethanol to 
acetaldehyde via their alcohol dehydrogenase 
(ADH) enzymes. Acetaldehyde is further 
oxidized to less harmful acetate mainly by the 
mitochondrial aldehyde dehydrogenase-2 
(ALDH2) enzyme. Genetic deficiency of 
ALDH2 strongly increases the risk of digestive 
tract cancers in heavy drinkers. Atrophic 
gastritis, a condition frequently associated with 
reduced gastric acidity and intragastric bacterial 
overgrowth, is also a risk factor for gastric 
cancer. Bacterial colonization of the stomach is 
also common during the use of medicines that 
inhibit gastric acid production, such as proton 
pump inhibitors.  
 
The aim of this study was to investigate 
ethanol metabolism in the mouth and in the 
hypochlorhydric stomach both in vivo and in 
vitro in order to find more evidence for the 
local carcinogenic action of acetaldehyde in 
humans. 
 
Firstly, we studied salivary acetaldehyde 
production in subjects with different ALDH2 
genotypes. Secondly, we examined whether the 
salivary acetaldehyde production can be 
reduced by using 4-methylpyrazole, an inhibitor 
of ADH. Thirdly, we studied the  
effect of proton pump inhibitors on gastric flora 
and acetaldehyde production from 
 
ethanol. Fourthly, we investigated both  
endogenous and exogenous ethanol metabolism 
in the stomach of patients with atrophic 
gastritis. Fifthly, we studied which microbes are 
responsible for acetaldehyde production in the 
hypochlorhydric stomach.  
 
These studies revealed that after alcohol 
ingestion ALDH2-deficient subjects have 
significantly higher in vivo salivary 
acetaldehyde levels than subjects with normal 
ALDH2. In addition to oral microflora, parotid 
salivary glands may also produce acetaldehyde 
into saliva. A single dose of 4-methylpyrazole 
before ethanol ingestion reduced the flushing 
reaction and both blood and salivary 
acetaldehyde levels in ALDH2-deficient 
subjects, but not in subjects with the normal 
ALDH2 genotype. Both iatrogenic 
hypochlorhydria and achlorhydria associated 
with atrophic gastritis led to intragastric 
bacterial overgrowth, and to marked microbial 
acetaldehyde production from ethanol both in 
vivo and in vitro. The most potent bacteria 
responsible for this seemed to be Neisseria 
species and Streptococcus salivarius, together 
with Enterobacteriaceae and yeasts, both of 
which have earlier been shown to be high 
acetaldehyde producers.    
 
Together with previous epidemiological data, 
the findings of this study provide strong 
evidence for the local carcinogenic action of 
acetaldehyde in the upper digestive tract in 
humans, and open a new genetic and 
microbiological approach for the pathogenesis, 
screening, and prevention of digestive tract 
cancers. 
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1. INTRODUCTION 
thanol in the form of various kinds of 
alcoholic beverages has been part of 
our social life for thousands of years. 
Unfortunately, alcohol is currently the most 
widely abused substance in the Western 
world, and can be regarded as one of the 
most severe public health problems of the 
modern society. Excessive drinking may 
lead to several liver diseases, such as “fatty 
liver”, hepatitis, and cirrhosis, though 
heavy drinking can also harm nearly every 
organ and system in the human body.  
 
Excessive alcohol consumption is one of 
the strongest risk factors for upper digestive 
tract cancers (Doll et al., 1999). Although 
the epidemiological data for this is 
convincing, the exact mechanism of 
ethanol-derived cancers has remained 
obscure, since ethanol itself is not a 
carcinogen (IARC, 1988). By contrast, the 
first metabolite of ethanol oxidation, 
acetaldehyde, has multiple carcinogenic 
effects according to cell culture and animal 
studies (IARC, 1999). Acetaldehyde has, in 
fact, been proposed to be the major factor 
behind ethanol-associated cancers. Recent 
epidemiological studies have reported an 
enhanced risk of upper digestive tract 
cancers among heavy-drinking Asian 
subjects with a genetically deficient ability 
to remove acetaldehyde (Yokoyama et al., 
1998a). 
 
The most important pathway for ethanol 
metabolism in the body involves two 
reactions and two enzymes catalyzing these 
reactions. In the first reaction, ethanol is 
converted to acetaldehyde by alcohol 
dehydrogenase (ADH), and in the second 
reaction acetaldehyde is oxidized to acetate 
by aldehyde dehydrogenase (ALDH): 
 
ADH             ALDH 
Ethanol    H Acetaldehyde    H Acetate  
 
During the past few years it has been shown 
that microbes of the digestive tract can also 
participate in ethanol metabolism 
(Jokelainen, 1997; Salaspuro, 1996, 1997). 
Many aerobic bacteria of the gastro-
intestinal tract possess ADH activity, and 
are thereby able to oxidize ethanol to 
acetaldehyde (Jokelainen et al., 1996a, 
Nosova et al., 1997), whereas opposite 
findings have been reported on ALDH 
activities of the alimentary tract microbes 
(Nosova et al., 1996, 1998; Muto et al., 
2000). Since the capacity of both the 
digestive tract microflora and mucosa to 
metabolize acetaldehyde to acetate seems to 
be limited, there may be local accumulation 
of acetaldehyde in the gastrointestinal tract 
in the presence of microbes and exogenous 
or endogenous alcohol (Koivisto and 
Salaspuro, 1996). In the upper digestive 
tract, high acetaldehyde levels have been 
detected in saliva even after a moderate 
dose of alcohol (Homann et al., 1997a). 
This acetaldehyde production is strongly 
influenced by individual factors and 
differences in oral flora (Homann et al., 
2000a). Considering its high reactivity, 
toxicity and carcinogenicity, the existence 
of acetaldehyde, especially at high 
concentrations, can be expected to have 
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deleterious effects. Therefore, studies on 
conditions associated with enhanced local 
production of acetaldehyde may provide 
important information for the understanding 
of the pathogenesis of alcohol-related 
diseases, and thus also contribute to the 
management and prevention of these diseases. 
 
The aim of the present study was to 
investigate ethanol metabolism and the 
local production of acetaldehyde in the 
upper digestive tract and in the 
hypochlorhydric stomach in order to gather 
more evidence for the local carcinogenicity 
of acetaldehyde in humans.    
 
REVIEW OF THE LITERATURE 
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2. REVIEW OF THE LITERATURE 
2.1. ALCOHOL AND THE DIGESTIVE TRACT 
Heavy and prolonged use of alcohol affects 
nearly every organ system of the human 
body. Liver damages, including “fatty 
liver”, alcoholic hepatitis and cirrhosis, are 
the best known examples of the effects of 
chronic alcohol consumption on the 
digestive tract. Excessive drinking is, 
however, also associated with a wide 
variety of other gastrointestinal symptoms 
that may lead either to acute or chronic 
digestive tract diseases. In addition, 
excessive alcohol consumption has long 
been recognized as a risk factor for 
alimentary tract cancers.   
 
Following oral alcohol intake the upper 
digestive tract, mouth, pharynx, larynx, 
esophagus, stomach and upper small 
intestine are exposed to high ethanol 
concentrations, and can thereby be directly 
affected by ethanol. However, since ethanol 
is rapidly and effectively transported 
through the circulation to more distal parts 
of the alimentary tract, chronic alcohol 
intake may also affect these parts. The most 
common gastrointestinal complaints among 
heavy drinkers are heartburn, nausea, 
vomiting, diarrhea and flatulence (Fields et 
al., 1994). These symptoms are associated 
with active alcohol use and are usually 
resolved after two weeks´ abstinence 
(Fields et al., 1994). 
 
Poor nutritional status is a common finding 
among lower-income and homeless 
alcoholics. The etiology of this, as well as 
the above mentioned gastrointestinal 
symptoms, has generally been thought to be 
of multifactorial origin (Salaspuro, 1993). 
Ethanol accounts for about a half of the 
caloric intake of such alcoholics. It 
therefore displaces normal nutrients, 
causing malnutrition (Lieber, 1995). 
Structural and functional changes in the 
small intestine may also lead to 
malabsorption and cause malnutrition. 
Other possible factors responsible for 
malnutrition are pancreatic exocrine 
insufficiency, reduced biliary secretion, and 
impaired hepatic metabolism of nutrients 
(Lieber, 1995; Salaspuro, 1993).      
Esophagus 
According to some earlier studies, acute 
alcohol ingestion may impair the function 
of the lower esophageal sphincter and 
decrease the primary peristalsis of the distal 
esophagus (Hogan et al., 1972; Mayer et al., 
1978). More recent studies have, however, 
reported opposite findings (Keshavarzian et 
al., 1987; Silver et al., 1986). There is also 
evidence indicating that alcohol may induce 
esophageal reflux and impair the acid 
clearance of the esophagus (Kaufman and 
Kaye, 1978; Vitale et al., 1987). This may 
explain the increased incidence of heartburn 
commonly reported among alcoholics. 
Other changes caused by excessive alcohol 
consumption in the same area are 
esophageal varices which are often 
responsible for upper gastrointestinal 
bleeding in alcoholics (Sutton and Shields, 
1995). The majority of heavy drinkers with 
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liver cirrhosis develop esophageal varices 
as a consequence of portal hypertension 
(Feinman et al., 1992).  
Stomach 
Chronic alcohol intake affects the histology 
of the fundic and especially the antral 
mucosa of the stomach (Dinoso et al., 1972; 
Parl et al., 1979). According to the study of 
Dinoso et al., even 50% of chronic 
alcoholics show changes of fundic gastritis 
and 84% show changes of antral gastritis, 
66% also having antral atrophic gastritis. In 
addition, chronic gastritis in alcoholic 
patients is known to develop into chronic 
atrophic gastritis at an earlier age than in 
non-alcoholic subjects (Parl et al., 1979). 
Bacterial overgrowth in the stomach is also 
associated with excessive drinking more 
often than with moderate alcohol 
consumption (Hauge et al., 1997). 
Furthermore, alcohol drinking may cause 
alterations in gastric emptying and gastric 
acid secretion. High intragastric ethanol 
concentration can delay gastric emptying 
and inhibit gastric acid secretion, whereas 
low concentrations can have the opposite 
effects (Feinman et al., 1992). 
Small intestine 
Acute ethanol ingestion causes histological 
changes, such as haemorrhagic erosions, 
subepithelial blebs, and infiltration of 
inflammatory cells in the lamina propria in 
the duodenum (Gottfried et al., 1978). 
Studies concerning chronic alcohol use 
have shown reduction in the villus height 
and a decreased mucosal surface area of 
villi in the small intestine (Bode et al., 
1982a, Persson 1991, Seitz et al., 1985). 
Heavy drinking is also known to promote 
bacterial overgrowth in the small intestine, 
which has been thought to be a 
consequence of the increased pH of the 
gastric juice (Bode et al., 1984a). Bacterial 
overgrowth, in turn, together with 
temporary destabilization of intercellular 
junctions may lead to increased 
permeability of the small intestine (Bode et 
al., 1991; Draper et al., 1983). Elevated 
permeability of the gut wall may lead to 
either increased loss of substances from 
blood to the intestinal lumen or increased 
uptake of normally non-absorbable 
substances like bacterial endotoxins from 
the gut to the portal blood (Persson, 1991). 
Increased permeability of the gut has also 
been proposed to be one of the mechanisms 
of alcoholic liver diseases (Keshavarzian et 
al., 1999; Parlesak et al., 2000; Thurman, 
1998). Interestingly, the paracellular 
permeability of the Caco-2 cell monolayer, 
a human colon adenocarcinoma cell line 
resembling normal small intestinal 
enterocytes, is reversibly increased by high 
acetaldehyde concentrations (Rao, 1998). 
Ethanol can also affect several enzymes 
that are located in the absorptive cells of the 
small intestine; decreased activities of 
disaccharidases, for example, have been 
demonstrated after chronic consumption of 
ethanol (Bode et al., 1982b). Reduced 
lactase activity as well as decreased oral-
caecal time in alcoholics may contribute to 
the diarrhea commonly observed in heavy 
drinkers (Keshavarzian et al., 1986; 
Persson, 1991). 
Large intestine 
Sustained excessive consumption of alcohol 
has been shown to produce marked changes 
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in the rectal histology. These reversible 
changes include a decreased number of 
goblet cells, inflammatory changes and 
alterations in the cell organelles (Brozinsky 
et al., 1978). Chronic alcohol use reduces 
colorectal transit time and affects colonic 
motility, both of which have been suggested 
to be associated with diarrhea frequently 
seen in alcoholics (Bouchoucha et al., 
1991).   
 
2.2. ALCOHOL AND DIGESTIVE TRACT CANCERS 
Cancer of the oropharynx and 
esophagus 
Excessive alcohol consumption is a strong 
determinant of an enhanced risk of cancers 
of the upper digestive tract (IARC, 1988). 
The increased risk of cancers of the mouth, 
pharynx, larynx and esophagus among 
heavy drinkers has been confirmed by 
many epidemiological studies (Blot, 1992; 
Blot et al., 1988; Boffetta et al., 1992; 
Brugere et al., 1986; Doll et al., 1999; 
Franceschi et al., 1990; Mashberg et al., 
1993). It has been estimated that alcohol 
consumption alone might account for about 
25 to 50% of cancers of these regions 
(Franceschi et al, 1990). Tobacco smoking 
is another well-known strong risk factor for 
the upper digestive tract cancers, and 
together with alcohol consumption these 
factors are the major causes of cancers in 
the upper gastrointestinal tract, accounting 
for as much as 75% of all cases in Europe 
(La Vecchia et al., 1997). Smoking and 
alcohol drinking are independent risk 
factors for upper digestive tract cancers, but 
the combined effect of these agents seems 
to be more than additive (Blot et al., 1988; 
Brugere et al., 1986, La Vecchia et al., 
1997). The risk of cancer increases 
proportionally with the number of cigarettes 
smoked and the amount of alcohol 
consumed. Even the regular use of 
mouthwash with a high alcohol content has 
been shown to increase the oral cancer risk 
(Winn et al., 1991). 
 
Poor nutritional status and low intake of 
micronutrients, fruit and green vegetables, 
genetic factors, certain papilloma virus 
infections, occupational hazards as well as 
poor oral hygiene and dental status, tooth 
loss, and dentition are all factors associated 
with a higher risk of upper digestive tract 
cancers (Bundgaard et al., 1995; Graham et 
al., 1977; Harris, 1997; La Vecchia et al., 
1997; Maier et al., 1993; Marshall et al., 
1992). These factors may also contribute to 
the ethanol-associated carcinogenesis of the 
upper gastrointestinal tract. Interestingly, 
poor dental status has recently also been 
shown to increase salivary acetaldehyde 
production up to twofold as compared to 
good dental status (Homann et al., 2001).       
Cancer of the stomach 
The association between alcohol 
consumption and stomach cancer is not as 
clear as that with other upper 
gastrointestinal tract cancers. The 
epidemiological data concerning the role of 
alcohol consumption in gastric 
carcinogenesis is controversial. Many 
studies either supporting (Correa et al., 
1985; Hoey et al., 1981; Wang et al., 1986; 
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Wu-Williams et al., 1990) or not 
supporting (Graham et al., 1967, 1972; 
Gray et al., 1992) this association have 
been published. The relative risk for a 
positive relationship has ranged from 1.5-
1.7 in previous case-control studies. 
However, a relative risk as high as 3.05 
has been reported in a study among the 
Japanese (Kato et al., 1992), who 
frequently have a genetically determined 
deficiency to metabolize acetaldehyde 
(Goedde et al., 1979). Yokoyama et al. 
(1998a) have found a high frequency of 
digestive tract cancers, including stomach 
cancer, in heavy-drinking individuals with 
deficient acetaldehyde removal. This 
supports the role of acetaldehyde in the 
carcinogenesis associated with alcohol use.  
 
As the role of ethanol in gastric 
carcinogenesis remains unclear, the 
association between cancer of the gastric 
cardia and excessive alcohol consumption 
may prove to be clearer, since this cancer 
seems to resemble a specific type of cancer 
of the lower esophagus and may share 
common risk factors such as tobacco 
smoking and alcohol drinking (Vaughan et 
al., 1995). The importance of understanding 
the risk factors for cancer of the gastric 
cardia is increasing, because the incidence 
rate of this cancer, opposite to stomach 
cancer, has been rising during the last 
decades (Blot et al., 1991; Botterweck et 
al., 2000; Devesa and Fraumeni, 1999).   
Cancer of the large intestine 
The association between alcohol 
consumption and cancer of the large 
intestine, similar to gastric cancer, has long 
been discussed. Epidemiological studies 
both for and against such an association 
have been published (Doll et al., 1999). 
There is, however, some evidence showing 
that alcohol consumption leads to a slightly 
increased risk of colorectal cancer with an 
estimated relative risk of 1.1, and that the 
risk of rectal cancer is more increased than 
the risk of colon cancer (Kune and Vitetta 
et al., 1992; Longnecker et al., 1990). 
Furthermore, the World Health Organiza-
tion Consensus Conference on Nutrition 
and Colorectal Cancer in 1999 declared that 
alcohol has a causal effect on colorectal 
carcinogenesis (Scheppach et al., 1999). 
Possible pathogenetic mechanisms 
in carcinogenesis 
It is clear that alcohol consumption is a risk 
factor for certain cancers discussed above. 
The exact mechanism responsible for this 
has been obscure, since there is no apparent 
evidence showing that ethanol itself is a 
carcinogen (Doll et al., 1999). However, 
many animal studies suggest that ethanol 
may act as a co-carcinogen at different sites 
of the body with a variety of chemical 
carcinogens (GriciLtM et al., 1982, 1984; 
Seitz et al., 1984).  
 
Alcoholic beverages may contain congeners 
or contaminants that can be carcinogenic. 
Special attention has recently been paid to 
N-nitroso compounds, which have been 
related to colorectal cancer (Knekt et al., 
1999). These compounds were found in 
high concentrations in some beers in the 
late 1970s (Walker et al., 1979). Some later 
studies have confirmed this finding (Riboli 
et al., 1991), whereas others have failed to 
support it (Potter and McMichael, 1986). 
According to Doll et al., 1999, the latest 
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consensus is that there is no difference in 
the cancer risk among different types of 
alcoholic beverages. However, an increased 
incidence of esophageal cancer has been 
reported in the area of France where 
calvados is a popular alcoholic beverage 
(Launoy et al., 1997). Interestingly, this 
type of alcoholic beverage has recently 
been shown to contain especially high 
amounts of acetaldehyde (Visapää et al., 
2001a).  
 
Prolonged alcohol intake induces 
microsomal cytochrome P450 enzymes, 
most importantly hepatic CYP2E1, which 
has a capacity to activate over 80 
toxicologically important xenobiotics to 
potentially carcinogenic products (Lieber, 
1997). Along with the activation of 
carcinogens, CYP2E1 mediates the 
breakdown of vitamin A (Leo and Lieber, 
1982). Since vitamin A has an important 
role in the maintenance of normal growth 
and cell differentiation, this may also be a 
significant factor in the development of 
cancer (Sporn and Roberts, 1983). In 
addition, ethanol may block the hepatic 
inactivation of carcinogens, and thereby 
increase the exposure to these compounds 
(Blot, 1992). 
 
Excessive alcohol consumption may either 
enhance nutritional deficiencies that 
increase the risk of cancer or reduce the 
intake and/or bioavailability of nutrients 
that may inhibit the development of cancer. 
Nutritional deprivation can lead to 
nutritional deficiencies that may alter 
epithelial cell chemistry and function, thus 
increasing susceptibility to carcinogens 
(Blot, 1992). An example of this is folate 
deficiency, which has been associated with 
an increased risk of colon cancer 
(Giovannucci et al., 1995). Folate acts as a 
methyl group donor in transmethylation 
reactions, e.g. in the methylation of DNA 
which is essential to normal gene 
expression. Decreased folate leads to the 
hypomethylation of DNA, which may 
initiate cancer development by impairing 
normal gene expression (Goelz et al., 1985; 
Kim et al., 1997). High levels of 
acetaldehyde have been reported to break 
down folate in vitro (Shaw et al., 1989). 
Moreover, it has been shown that alcohol 
administration to rats for two weeks leads 
to local folate deficiency of the colonic 
mucosa (Homann et al., 2000b). These 
findings indicate that high alcohol intake 
together with low folate can play a major 
role in the initiation of colorectal cancer 
(Giovannucci et al., 1995; Homann et al., 
2000b). 
 
Alcohol is recognized as an immuno-
suppressant, and this effect has also been 
suggested to be a contributing factor in the 
increased rate of cancer in alcoholics. 
However, the role of ethanol-induced 
immunosuppression in alcohol-related 
cancers has remained questionable, since 
the incidence of cancers of the immune 
system itself, such as lymphoma, the most 
common cancer associated with depressed 
immune function, is not increased by 
alcohol consumption (Blot, 1992). 
 
The possible mechanisms through which 
acetaldehyde can be related to ethanol-
associated carcinogenesis will be discussed 
separately in chapter 2.8., as well as the 
effect of genetic factors, i.e. polymorphism 
of alcohol-metabolizing enzymes, in 
chapter 2.4.   
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2.3. UPPER GASTROINTESTINAL MICROFLORA 
Microbes in saliva 
The composition of the microflora varies 
greatly from site to site in the mouth. 
Studies regarding the microbial flora of the 
mouth often deal with the microbiota in the 
dental plaque and bacteria dislodged and 
exfoliated from oral sites to saliva. Ethanol 
is present in saliva in concentrations 
comparable to those in blood (Jones, 1979), 
and saliva is in close contact with the 
mucosa of the upper digestive tract. For the 
purposes of this thesis, the focus of the 
following overview is on the microbes in 
saliva. 
 
Human saliva contains approximately 107-
109 microorganisms per millilitre. The 
microbes in saliva originate from various 
parts of the oral cavity, i.e. the teeth, 
tongue, cheek, and pharyngeal mucous 
membranes (Herrera et al., 1988). 
Streptococci, especially viridans group 
streptococci, are the most common aerobic 
group of bacteria at all sites of the mouth. 
This group of Gram-positive cocci accounts 
for approximately 45% of the total 
cultivable microbes in saliva (Marsh, 1980). 
Streptococcus salivarius, Streptococcus 
mutans, and N-haemolytic streptococci, 
such as Streptococcus sanguis, 
Streptococcus mitis, Streptococcus oralis 
and anginosus group streptococci are the 
most numerous species and groups 
belonging to this group. Other aerobic 
microorganisms often isolated from saliva 
are Gram-positive Stomatococcus, 
Staphylococcus, Micrococcus, and 
Corynebacterium species and Gram-
negative Neisseria and Haemophilus 
species (Jousimies-Somer et al., 2002; 
Marsh, 1980). Yeasts also belong to the 
aerobic microbial flora of the mouth, and 
can be found in about 40% of clinically 
healthy mouths (Marsh, 1980). Candida 
albicans species are the most numerous and 
prevalent yeasts in the oral cavity 
(Stenderup, 1990). Anaerobic bacteria in 
saliva are mainly comprised of Gram-
positive rods like Actinomyces, 
Lactobacillus, Bifidobacterium and many 
novel Eubacterium-like genera and species, 
Gram-negative rods belonging to 
Prevotella, Fusobacterium, Porphyromonas, 
Campylobacter and Bacteroides genera, 
and Gram-negative cocci of Veillonella and 
Capnocytophaga species (Jousimies-Somer 
et al., 2002; Marsh, 1980).       
Microbes in gastric juice 
Since the normal pH of the gastric juice is 
below 3, the stomach is usually free of 
microbes. However, even in normochlorhydric 
persons, the stomach is not sterile all the time; 
e.g. during meals the acid in gastric juice is 
buffered, allowing the gastric pH to rise 
above 4 when the most acid resistant 
swallowed oral microbes can survive in the 
stomach (Drasar et al., 1969). The pH 
usually drops again below 3 quite fast after 
eating and the microbes are killed (Drasar 
et al., 1969; Hill, 1995). Consequently, 
permanent gastric flora can only occur 
when gastric acid secretion is impaired to 
the extent that the pH does not fall below 3-
4. Microbial proliferation leading even to 
microbial overgrowth can be expected in 
the stomach if the pH of the gastric juice 
exceeds 5 (Gray and Shiner, 1967; 
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Stockbruegger, 1985). Gastric microbial 
overgrowth is a common finding in 
conditions with gastric hypo- or 
achlorhydria such as chronic atrophic 
gastritis, pernicious anemia and gastric 
surgery with vagotomy (Drasar et al., 1969; 
Stockbruegger et al., 1984). The prolonged 
use of drugs inhibiting gastric acid 
secretion, e.g. antacids, histamine-2-
receptor antagonists and proton pump 
inhibitors, can also result in resident gastric 
colonization (Ruddell et al., 1990; 
Stockbruegger, 1985; Verdu et al., 1994). 
The primary source of the flora of the 
neutral stomach is the oral cavity. Contrary 
to the prevalence of aerobes and anaerobes 
in saliva, aerobes are usually more 
numerous in the gastric juice than 
anaerobes; the total counts for aerobes 
being 106-107 and for anaerobes 105-106
colony forming units per millilitre (Hill, 
1985). The most commonly encountered 
aerobic bacteria in the gastric juice are 
viridans group streptococci, Stomatococcus, 
Neisseria, and Corynebacterium species, 
and the most prevalent and numerous 
anaerobes are Actinomyces, Prevotella, 
Lactobacillus, and Veillonella species (Hill, 
1985, 1995). Occasionally, some bacteria 
belonging to Enterobacteriaceae can also 
be isolated from the neutral gastric juice 
(Drasar et al., 1969; Hill, 1985, 1995).   
 
Helicobacter pylori infection in the 
stomach makes an exception to what was 
discussed above; it can survive and 
proliferate in the acidic stomach. 
Helicobacter pylori colonizes the mucosa 
of the stomach below the mucin barrier, and 
is thus protected from the luminal acid. 
Under the mucosal barrier it is still 
protected from the local acid production by 
its acid neutralizing urease activity, thus 
allowing the bacteria to proliferate 
(Marshall et al., 1990).      
Alterations caused by chronic 
alcohol intake 
So far, there are no well-controlled studies 
showing whether chronic alcohol 
consumption directly alters the oral flora. 
Studies done by Harris et al. (1996, 1997) 
suggest that alcohol abusers have not as 
good dental hygiene as abstainers or 
moderate alcohol consumers. Poor dental 
hygiene may lead to overgrowth of some 
microbes in the oral cavity. In addition, 
deficient diets and the suppressed immune 
defence system may favour microbial 
proliferation in the mouth (MacGregor, 
1986; Oksala, 1990). Furthermore, many 
alcohol abusers are also heavy tobacco 
smokers (Harris et al., 1996), and smoking 
is known to increase the presence of yeasts 
and Gram-positive bacteria in the oral 
cavity (Colman, 1976; MacGregor, 1988; 
Sakki and Knuuttila, 1996). 
 
Regarding gastric flora, mucosal bacterial 
overgrowth in the stomach is more 
prevalent in heavy drinkers and with higher 
microbial counts than in non-alcoholic 
controls (Hauge et al., 1997). This finding 
may result from the increased pH of the 
gastric juice.  
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2.4. ALCOHOL METABOLIZING ENZYMES 
Alcohol dehydrogenase 
Alcohol dehydrogenase (ADH) is the main 
enzyme catalyzing the oxidation of ethanol 
to acetaldehyde in mammals. The reversible 
reaction is as follows: 
 
CH3CH2OH + NAD+ H CH3CHO + 
NADH + H+
ADH is an NAD+(NADP+)-dependent 
enzyme that is expressed as numerous 
isoenzymes with different kinetic properties 
and substrate preferences. Human ADHs 
can be grouped into five classes, I-V, based 
on the characteristics of their primary 
structure (Jörnvall and Höög, 1995). 
Functional ADH enzymes are dimers 
consisting of either two similar subunits or 
two distinct subunits belonging to the same 
class. ADHs are mostly present in the 
cytosolic fraction of the cells. 
 
The most important enzymes in hepatic 
ethanol elimination are the class I ADHs. 
These enzymes have both a low Km (about 1 
mM) and a high Vmax for ethanol, and 
consequently, they are capable of 
eliminating ethanol from the blood at a 
constant rate to very low ethanol 
concentrations. Since the Km of ADH for 
acetaldehyde is only 0.6 mM, acetaldehyde 
needs to be rapidly oxidized further to 
acetate at the same time with ethanol 
oxidation to keep the reverse ADH-mediated 
reaction running in the right direction (Blair 
and Vallee, 1966). Ethanol oxidation to 
acetaldehyde via ADH increases the liver 
NADH/NAD ratio, which leads to a 
significant reduction in the redox state of 
this organ. This phenomenon also accounts 
for many acute metabolic effects of ethanol, 
such as the inhibition of hepatic 
gluconeogenesis, the decrease in citric acid 
cycle activity, and the impairment of fatty 
acid oxidation (Lieber, 1994).  
 
Class I isoenzymes are expressed by three 
genes, ADH1, ADH2, and ADH3, which 
encode protein subunits N, Q, and R. ADH2 
and ADH3 are polymorphic genes; three 
different allelic forms (ADH2*1, ADH2*2, 
and ADH2*3) have been found for ADH2, 
and two (ADH3*1 and ADH3*2) for ADH3. 
The distribution of these alleles differs by 
race; the frequency of the ADH2*1 allele, for 
example, has been estimated to be about 85% 
in Caucasian populations, but only 15% in 
Asian populations, whereas the ADH2*2 
allele is predominant in Asians (Bosron and 
Li, 1986; Goedde et al., 1992). The frequency 
of ADH3*1 is approximately 50-60% in 
Caucasians and higher than 90% in Asians 
(Bosron and Li, 1986). Alleles ADH2*2 and 
ADH3*1 encode the most active enzymatic 
forms of the protein subunits, e.g. individuals 
having the ADH3*1/*1 genotype metabolize 
ethanol to acetaldehyde 2.5 times faster than 
individuals with other ADH3 genotypes, and 
individuals with the ADH2*2/*2 genotype 
even 40 times faster than individuals with the 
ADH2*1/*1 genotype (Bosron and Li, 1986). 
Interestingly, an enhanced risk of upper 
digestive tract cancers has been associated 
with the rapidly metabolizing ADH3 
genotype in some studies (Coutelle et al., 
1997; Harty et al., 1997; Seitz et al., 2001), 
while two studies have reported opposite 
findings (Bouchardy et al., 2000; Olshan et 
al., 2001).   
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The mucosa of the gingiva and tongue 
expresses class III and class IV ADH 
isoenzymes. The estimated Km value for 
ethanol of the gingival ADH is 27 mM 
(Dong et al., 1996). The main ADH 
isoenzyme of the esophagus belongs to 
class IV, although some other ADHs of 
class I have also been observed. The Km
value for ethanol of the esophageal class IV 
is 12 mM (Yin et al., 1993). Both of these 
high Km values indicate that ethanol can be 
oxidized both in the mouth and in the 
esophagus during and after ethanol 
challenge. Additionally, the esophagus is 
known to possess the highest ADH activity 
of the organs in the digestive tract with a 
rate per milligram of protein similar to that 
of the liver, and about four times that of the 
stomach enzyme (Parés and Farrés, 1996).  
 
The stomach expresses many ADH 
isoenzymes, of which classes I and IV are 
postulated to be the most important ones. 
Class I ADH’s Km value for ethanol is 1 
mM and class IV ADH’s 40 mM (Parés et 
al., 1992; Seitz and Oneta, 1998; Yin et al., 
1997). Since class IV ADH is characteristic 
for the upper digestive tract and class I for 
the rest of the intestinal tract, the stomach 
seems to be the transition site for the 
expression of these ADH classes (Yin et al., 
1997). The gastric ADHs have been 
suggested to play a marked role in the first- 
pass metabolism of ethanol. According to 
this theory, intragastric ethanol metabolism 
explains the differences in blood ethanol 
concentrations observed after either oral or 
intravenous ethanol administration 
(Julkunen et al., 1985). This theory has long 
been a subject of debate and its significance 
in total ethanol elimination still remains 
unclear. Seitz and Pöschl (1997) estimated 
that the first-pass metabolism of ethanol 
accounts for 1 to 20% of the total ethanol 
metabolism. 
 
As mentioned earlier, the small and large 
intestine exhibit mainly class I ADH, with a 
Km value for ethanol of 1-2 mM (Seitz and 
Oneta, 1998). This value corresponds to the 
ethanol concentrations commonly measured 
from the colon during alcohol consumption. 
The ADH activity of the colonic mucosa is 
similar to gastric ADH activity (Seitz et al., 
1996). This suggests that ethanol may be 
effectively metabolized to acetaldehyde by 
the colonic mucosa as well. 
 
The ADH-mediated reaction can be reduced 
by 4-methylpyrazole (4-MP), a drug that 
competitively inhibits the oxidation of 
ethanol to acetaldehyde by ADH (Li and 
Theorell, 1969; Salaspuro, 1985). The 
inhibitory effect of 4-MP can also be seen 
in the dose-dependent reduction of the total 
ethanol elimination rate (Salaspuro, 1985). 
4-MP is used in the clinical practice in the 
treatment of methanol and ethylene glycol 
poisonings (Jacobsen and McMartin, 1997). 
In addition, it is efficient in the 
management of the disulfiram-alcohol 
reaction (Lindros et al., 1981) and the so-
called flushing reaction of ALDH2-
deficient subjects (Inoue et al., 1985).  
Aldehyde dehydrogenase 
The second reaction in alcohol metabolism, 
the oxidation of acetaldehyde to acetate, is 
catalyzed by aldehyde dehydrogenase 
(ALDH). Like ADH, ALDH needs 
NAD+(NADP+) in order to act as a catalyst, 
and it is also expressed as many 
isoenzymes. In humans, at least 4-5 ALDH 
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isoenzyme classes have been isolated, and 
they are found both in the cytosolic and in 
the mitochondrial fraction of the cells 
(Agarwal, 1997). The isoenzyme mainly 
responsible for acetaldehyde oxidation is 
the mitochondrial class II ALDH (ALDH2), 
which has a micromolar Km value and a 
high affinity for acetaldehyde (Lands, 
1998). ALDH1 and ALDH5 also have 
micromolar Km’s for acetaldehyde, while 
most ALDH3 and ALDH4 isoenzymes 
possess millimolar Km values.  
 
The ALDH2 enzyme is polymorphic in 
humans, having two allelic forms, 
ALDH2*1 and ALDH2*2. The ALDH2*2 
allele is a result of a single point mutation 
in the area of chromosome six coding the 
normal ALDH2*1 allele. Individuals 
homozygous for this mutated ALDH2*2 
allele lack ALDH2 activity, whereas 
heterozygous individuals with the 
ALDH2*1/*2 genotype have 30-50% of the 
activity of ALDH2*1 homozygotes (Crabb 
et al., 1989). Certain Asian populations 
show relatively high frequencies of the 
ALDH2*2 allele, e.g. about 50% of the 
Japanese express this ALDH2 variant, 
while it is extremely rare in Caucasian 
populations (Goedde et al., 1979, 1992). 
Partial or total inactivation of ALDH2 leads 
to the accumulation of acetaldehyde in the 
body. Blood acetaldehyde levels have been 
reported to be six and twenty times higher 
in subjects heterozygous and homozygous 
for the mutant allele, respectively, than in 
persons with normal ALDH2 activity 
(Yokoyama, 1996a). Elevated blood 
acetaldehyde levels can cause numerous 
unpleasant symptoms, such as flushing of 
the face and body, tachycardia, drop in 
blood pressure, headache, and nausea. 
Therefore, the homozygous form of the 
mutant ALDH2*2 allele offers almost full 
protection against alcoholism, but despite 
the flushing symptoms, heterozygotic 
subjects may become heavy drinkers or 
even alcoholics (Chen et al., 1999; Higuchi 
et al., 1994; Peng et al., 1999). Alcohol-
drinking individuals with low-activity 
ALDH2 can thereby be considered as 
human “knock-out models” for deficient 
acetaldehyde removal. Interestingly, many 
recent epidemiological studies have shown 
an increased risk of digestive tract cancers, 
and especially of upper digestive tract 
cancers, among heavy-drinking ALDH2-
deficient subjects (Murata et al., 1999; 
Tanabe et al., 1999; Yokoyama et al., 
1996a-c, 1998a,b). 
 
Since the liver is the main organ for ethanol 
oxidation, the bulk of the ALDHs exist 
there. However, other organs also exhibit 
ALDH isoenzymes. ALDH3 has been 
detected in the mouth (Dong et al., 1996), 
and esophagus, which also exhibits ALDH1 
(Yin et al., 1993). The stomach expresses 
ALDH classes 1, 2, and 3, which suggests 
that this organ could be a significant place 
for acetaldehyde oxidation (Yin et al., 
1997). ALDH classes 1 and 2 have been 
found in the human duodenum (Liao et al., 
1991) and classes 1, 2 and 3 in the colonic 
mucosa, but the expression of ALDH2, in 
particular, seems to be very low (Yin et al., 
1994). 
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2.5. DISTRIBUTION OF ETHANOL IN THE BODY 
Due to its small molecular size, good water 
solubility, but poor solubility in lipids, 
ethanol is absorbed from the 
gastrointestinal tract by simple diffusion 
(Wallgren and Barry III, 1970). 
Approximately 75 % of the ingested 
ethanol is absorbed from the proximal small 
intestine, duodenum and upper jejunum and 
about 25 % from the stomach. Delayed 
gastric emptying decreases the rate of 
ethanol absorption (Oneta et al., 1998). 
Eating, for example, is known to delay 
gastric emptying, and therefore slower rises 
and lower peak concentrations in blood 
ethanol levels can be detected after a meal 
(Jones et al., 1997). 
 
After absorption, ethanol is distributed via 
circulation and diffusion throughout the 
body fluids. Alcohol rapidly equilibrates 
with the bloodstream in organs with dense 
vascularization and rich blood supply, such 
as the brain, lungs, and liver. Accordingly, 
the distribution of ethanol to the resting 
skeletal muscle is slow, since only part of 
the capillaries are functioning (Dundee et 
al., 1971). Due to ethanol’s poor lipid  
solubility, tissue lipids can take up only  
 
about 4 % of the amount of alcohol 
dissolved in a corresponding volume of 
water. Thus women, having smaller total 
body water volumes than men, reach higher 
blood ethanol levels if both consume equal 
amounts of alcohol (Riveros-Rosas et al., 
1997). The total volume of the body water 
is reduced with age, and changes similar to 
sex-related differences in blood ethanol 
levels can also be detected with ageing. The 
distribution of ethanol in the body is mainly 
related to the water content of various 
organs and tissues. Consequently, after 
alcohol consumption, ethanol concentra-
tions in the terminal ileum (Halsted et al., 
1973), colon (Levitt et al., 1982), and oral 
cavity (Jones et al., 1979) are equal to those 
in the blood. In contrast, the alcohol levels 
in urine are slightly higher than those in 
blood (Bendtsen et al., 1999). 
 
About 90-95% of the absorbed ethanol is 
metabolized completely in the body, and 
excreted as CO2 and water, so only a minor 
part of the ingested alcohol is excreted 
unaltered via expired air, sweat, and urine 
(Holford, 1987).   
2.6. ETHANOL METABOLISM IN THE DIGESTIVE TRACT 
Hepatic ethanol metabolism 
It is generally agreed that most of the 
ethanol metabolism takes place in the liver. 
Under normal conditions the liver 
eliminates approximately 75-90% of 
ethanol (Agarwal and Goedde, 1990). In 
severe hepatic cirrhosis, the extrahepatic 
ethanol elimination can, however, rise up to 
40% (Utne and Winkler, 1980). There are 
three metabolic pathways for ethanol 
oxidation in the liver: cytosolic alcohol 
dehydrogenase (ADH), microsomal ethanol 
oxidizing system (MEOS), and catalase, of 
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which the alcohol dehydrogenase pathway 
is the most important one. Because of the 
essential role of ADH in this thesis, the 
characteristics of the ADH-mediated 
pathways have been discussed separately in 
chapter 2.4.   
 
The cytochrome P-450-dependent micro-
somal ethanol oxidizing system was first 
described by Lieber and DeCarli in 1968. It 
oxidizes ethanol to acetaldehyde as follows: 
 
CH3CH2OH + NADPH+ + H + O2 U
CH3CHO + NADP+ + 2 H2O
In humans, CYP2E1 is the major 
cytochrome fraction responsible for ethanol 
oxidation. The MEOS contributes to 
ethanol elimination only at high blood 
ethanol levels since its Km for ethanol is 7-
10 mM. It has been estimated that the 
MEOS accounts only for about 1-5% of the 
total in vivo ethanol metabolism (Ingelman-
Sundberg, 1997). The role of the adaptive 
CYP2E1 in the total ethanol elimination 
may, however, increase up to 10% in 
chronic alcohol consumers with constant 
high blood ethanol levels (Lieber, 1988). 
 
Catalase, a haemoprotein located in the 
peroxisomes, can oxidize ethanol to 
acetaldehyde as follows:  
 
CH3CH2OH + H2O2 U CH3CHO + 2 H2O
Since the presence of hydrogen peroxide is 
essential for catalase to be able to oxidize 
ethanol, the reaction is limited by the rate of 
its generation. The rate of hydrogen 
peroxide production in the liver is quite low 
(Boveris et al., 1972), which suggests that 
catalase plays only a minor role, less than 
2%, in hepatic ethanol metabolism. 
Other sites for ethanol metabolism 
Other organs are also capable of oxidizing 
ethanol, although to a lesser extent than the 
liver. As already discussed in chapter 2.4., 
direct determinations of ADH activity in 
human tissues have revealed that ethanol 
may be actively metabolized in the 
digestive tract by the mucosa of the mouth 
(Dong et al., 1996), esophagus (Yin et al., 
1993), stomach (Yin et al., 1997), and both 
the small and large intestine (Seitz et al., 
1996; Seitz and Oneta, 1998). In addition, 
ethanol oxidation may occur in the kidneys 
(Leloir and Muñor, 1938), bone marrow 
cells (Wickramasinghe, 1981), lungs (Pik-
karainen et al., 1981), testes (Boleda et al., 
1989), and pancreas (Estival et al., 1981).  
 
2.7. MICROBIAL ETHANOL METABOLISM 
Alcoholic fermentation  
Under anaerobic conditions, microbes 
cannot produce energy via respiration using 
oxygen as a terminal electron acceptor, so 
they derive energy via fermentation. In 
alcoholic fermentation, the pyruvate formed 
from glucose by glycolysis is converted 
anaerobically to ethanol and CO2. The final 
step in alcoholic fermentation is the 
reduction of acetaldehyde to ethanol via 
microbial ADHs (Reid and Fewson, 1994). 
A detailed description of this phenomenon 
has been given for Escherichia coli (Clark, 
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1989; Dawes and Foster, 1956; Still, 1940; 
Wong and Barrett, 1983), group N 
streptococci (Lees and Jago, 1976), and 
Enterobacteriaceae in general (Salveson 
and Bergan, 1981). 
 
Small amounts of endogenous ethanol can 
be found in the body fluids of mammals 
that have not received any alcohol. This 
phenomenon was first suggested to be a 
result of microbial alcohol fermentation by 
Krebs and Perkins in 1970. The finding was 
later confirmed in jejunal blind-loop rats 
with bacterial overgrowth (Baraona et al., 
1986). In humans, marked endogenous 
ethanol levels have been measured in 
midjejunal aspirates of patients suffering 
from tropical sprue, a condition associated 
with intestinal overgrowth of Entero-
bacteriaceae (Klipstein et al., 1973), and in 
the venous blood of patients after a 
jejunoileal bypass operation, a condition 
also known to lead to intestinal bacterial 
overgrowth (Mezey et al., 1975). In 
addition, small quantities of ethanol have 
been found in the gastric juice of patients 
receiving cimetidine or antacids. This has 
been suggested to result from the increased 
intragastric pH and microbial colonization 
of the stomach (Bode et al., 1984b). 
Moreover, microbial alcohol fermentation 
of ingested carbohydrates leading even to 
signs of ethanol intoxication has been 
reported to occur in Japanese patients (Kaji 
et al., 1984).   
Ethanol oxidation 
Under aerobic conditions, the reaction 
catalysed by microbial ADHs runs in the 
opposite direction of that described above 
(Maconi et al., 1988). In this reaction, 
ethanol is oxidized to acetaldehyde, and in 
that way used as an energy and carbon 
source. The characteristics of the 
microbially mediated acetaldehyde 
production from ethanol have been 
established in several in vitro and in vivo 
studies which will be reviewed in the 
following sections. 
 
In the upper digestive tract, significant in 
vitro microbially mediated acetaldehyde 
production has been reported when human 
mouth and bronchopulmonary washings 
were incubated with ethanol (Jauhonen et 
al., 1982; Miyakawa et al., 1986; 
Pikkarainen et al., 1981). Furthermore, the 
mouth washings of patients with 
oropharyngeal cancer have been shown to 
produce increased amounts of acetaldehyde 
in vitro. This suggests that microbially 
mediated acetaldehyde production may be 
involved in ethanol-associated organ 
toxicity (Jokelainen et al., 1996b). Marked 
production of acetaldehyde has also been 
demonstrated in saliva in both in vivo and 
in vitro studies. This acetaldehyde 
production can be significantly reduced by 
using antiseptic chlorhexidine mouthwash, 
which indicates that acetaldehyde 
production is of microbial origin (Homann 
et al., 1997a). The same study also showed 
that there is a highly significant positive 
correlation between in vivo and in vitro 
salivary acetaldehyde production. Later in 
vitro studies have revealed that salivary 
acetaldehyde production is strongly 
influenced by individual factors, heavy 
tobacco smoking and alcohol drinking 
being the most important factors, which 
increase the production of acetaldehyde in 
saliva (Homann et al., 2000a). In addition, 
it has been demonstrated that especially 
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some oral Candida albicans strains have a 
high capacity to produce acetaldehyde from 
ethanol in vitro (Tillonen et al., 1999a). 
Marked cytosolic ADH activity has also 
been found in Helicobacter pylori, which 
can, consequently, produce significant 
amounts of acetaldehyde when incubated 
with ethanol in vitro (Roine et al., 1992, 
1995; Salmela et al., 1993, 1994). 
 
Regarding the small and large intestine, the 
first findings of microbial ethanol 
metabolism were reported as early as 1940 
when Still showed that Escherichia coli 
possesses ADH activity. As mentioned 
earlier, this finding was later confirmed by 
many others. Baraona et al. showed in 1986 
that microbial intraintestinal acetaldehyde 
production from ethanol also occurs in vivo 
in rats with a jejunal self-filling 
diverticulum and bacterial overgrowth. 
Furthermore, Seitz et al. (1990) found that 
the acetaldehyde concentration of the rectal 
mucosa was markedly higher in 
conventional rats than in germ-free rats 
after ethanol administration. A new 
microbiological approach for acetaldehyde 
production and the pathogenesis of ethanol-
related gastrointestinal diseases was opened 
up by studies of Jokelainen et al., who first 
described a bacteriocolonic pathway for 
ethanol oxidation. These in vitro studies 
showed that human colonic contents can 
produce acetaldehyde from ethanol in a 
dose-dependent manner (Jokelainen et al. 
1994), and that certain aerobic colonic 
bacteria can produce high amounts of 
acetaldehyde from ethanol by their ADH 
enzymes (Jokelainen et al. 1996a). In 
addition, it was demonstrated in vivo that 
both intragastric and intravenous ethanol 
administration to pigs lead to a marked 
increase in intracolonic acetaldehyde levels 
(Jokelainen et al. 1996c). Later in vitro 
studies have characterized the ADHs of 
human colonic bacteria in more detail 
(Nosova et al., 1997), and revealed that 
ethanol oxidation by Escherichia coli can 
also occur under microaerobic (6% O2)
conditions (Salaspuro et al., 1999). 
Moreover, high acetaldehyde levels have 
been detected in the caecal samples of rats 
after an acute intraperitoneal dose of 
ethanol (Visapää et al., 1998).  
 
The bacteriocolonic pathway for ethanol 
oxidation can be modulated by treatment 
with antibiotics. Ciprofloxacin, which 
decreases the number of aerobic bacteria in 
the large intestine, also reduces the total 
ethanol elimination rate approximately by 
9% and the faecal ADH activity both in rats 
(Jokelainen et al., 1997) and in humans 
(Tillonen et al., 1999b). Moreover, in rats 
treatment with ciprofloxacin totally 
abolishes the enhancement in the ethanol 
elimination rate caused by chronic ethanol 
administration (Nosova et al., 1999). The 
opposite effects can be found with 
metronidazole treatment, which is known to 
reduce the anaerobic flora of the large 
intestine, thus enhancing the growth of 
ADH-containing aerobes in the gut 
(Tillonen et al., 2000; Visapää et al., 
2001b). The rats receiving metronidazole 
have five times higher intracolonic 
acetaldehyde levels than the rats receiving 
only ethanol (Tillonen et al., 2000).    
Acetaldehyde oxidation 
Yeasts and anaerobic bacteria possess 
aldehyde dehydrogenase activity (Steinman 
and Jakoby, 1968; Burdette and Zeikus, 
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1994). Furthermore, Escherichia coli 
(Dawes and Foster, 1956; Wong and 
Barrett, 1983) and many other bacteria 
belonging to Enterobacteriaceae (Nosova 
et al., 1996), as well as some oral Neisseria 
species (Muto et al., 2000) are known to 
exhibit ALDH activity. However, the 
ability of bacterial ALDHs to oxidize 
acetaldehyde to acetate seems to be rather 
low as compared to their ADH activity 
(Nosova et al., 1998, Muto et al., 2000). 
Considering the fact that ALDH activity 
e.g. in the colonic mucosa is rather low 
(Koivisto and Salaspuro, 1996), these 
studies suggest that acetaldehyde may 
accumulate in the gastrointestinal tract.   
 
2.8. ORGAN TOXICITY OF ACETALDEHYDE 
Cyto- and genotoxicit y
Acetaldehyde has many mutagenic and 
carcinogenic effects both in cell culture 
conditions and in animal studies (IARC, 
1999). It can induce chromosomal 
aberrations and micronuclei and/or sister 
chromatid exchanges in cultured 
mammalian cells (Dellarco, 1988; IARC, 
1999), and gene mutations in human 
lymphocytes (He and Lambert, 1990). The 
ability of acetaldehyde to form DNA-DNA 
and/or DNA-protein cross-links may be 
responsible for the induction of these 
cytogenetic effects. In vitro studies with the 
human adenocarcinoma cell line Caco-2 
show that acetaldehyde decreases some 
brush border enzyme activities and alters 
certain cell properties including an increase 
in the proliferation rate and disturbed cell 
differentiation. These results also suggest 
more aggressive and invasive tumour 
behaviour in vivo (Koivisto and Salaspuro, 
1997, 1998).  
 
Studies with experimental animals have 
provided sufficient evidence for the 
carcinogenicity of acetaldehyde in animals 
(IARC, 1999). An acetaldehyde inhalation 
experiment in rats showed an increased 
incidence of carcinomas in the nasal 
mucosa (Woutersen et al., 1984). Another 
inhalation study with hamsters resulted in 
an enhanced number of laryngeal 
carcinomas (Feron et al., 1982). In addition, 
a study where rats were given water with or 
without acetaldehyde showed marked 
histopathological hyperplastic and hyper-
proliferative changes in the tongue, 
epiglottis, and forestomach in the animals 
receiving acetaldehyde (Homann et al., 
1997b).  
 
Recent studies on the associations between 
genotypes of ethanol- and acetaldehyde-
metabolizing enzymes and cancer risk have 
provided strong epidemiological evidence 
for the carcinogenic action of acetaldehyde 
in humans. Some studies report an 
enhanced risk of upper gastrointestinal tract 
tumours to be associated with the rapid 
metabolizing ADH3*1/*1 genotype, which 
leads to higher and quicker production of 
acetaldehyde (Coutelle et al., 1997; Harty et 
al., 1997; Seitz et al., 2001). Very recently, 
increased salivary acetaldehyde levels after 
alcohol consumption were detected in 
individuals with this genotype (Li et al., 
2001).  
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Furthermore, ALDH2-deficiency, which 
leads to longer acetaldehyde exposure, 
increases the risk of alcohol-associated 
cancers in the oropharynx, larynx, 
esophagus, stomach, colon, and lungs, but 
not in the liver (Murata et al., 1999; Tanabe 
et al., 1999; Yokoyama et al., 1996a-c, 
1998a,b). This phenomenon has so far been 
hypothesized to arise from the systemic 
effects of blood’s elevated acetaldehyde 
concentration. Most interestingly, however, 
all the organs with enhanced cancer risk are 
covered with microbes. They are also 
places where microbial ethanol metabolism 
and acetaldehyde production have been 
described (Homann et al., 1997; Jokelainen 
et al., 1996c; Miyakawa et al., 1986; 
Pikkarainen et al., 1981). These findings, 
thus, suggest that local microbially 
mediated acetaldehyde production from 
ethanol might be involved in the 
pathogenesis of these cancers.      
Acetaldehyde-protein adducts 
The electrophilic nature of the carbonyl 
carbon of acetaldehyde makes it suitable for 
potential nucleophilic attacks (Sorrell and 
Tuma, 1987). As nucleophilic groups are 
commonly present in proteins, they are the 
natural binding targets for acetaldehyde in 
various tissues. The binding of 
acetaldehyde with proteins results in the 
formation of two types of products, which 
are classified as unstable and stable 
acetaldehyde-protein adducts (Sorrell and 
Tuma, 1985). Subsequently, the unstable 
adducts can either re-dissociate to 
acetaldehyde and protein or be stabilized by 
treatment with reducing agents such as 
NADH to stable acetaldehyde-protein 
adducts. The stable adducts appear to be the 
most likely candidates to produce toxic 
effects (Nicholls et al., 1992). 
 
Acetaldehyde binds covalently to many 
cellular and extracellular proteins in vitro 
(Nicholls et al., 1992). In vivo,
acetaldehyde forms multiple adducts with 
proteins, such as hemoglobin (Sillanaukee 
and Koivula, 1990). Furthermore, adduct 
formation occurs in the liver of 
experimental animals and humans (Lin et 
al., 1988, Niemelä et al., 1991). Immuno-
histochemical techniques have been used to 
localize adducts in the liver. In these 
studies, acetaldehyde-protein adducts have 
been detected in the cytoplasm of the 
perivenular hepatocytes (Niemelä et al., 
1991), in the areas of active fibrogenesis in 
alcoholic patients (Holstege et al., 1994), in 
the rough endoplasmic reticulum, and in 
some peroxisomes of hepatocytes, as well 
as in myofibroblasts and Ito cells (Paradis 
et al., 1996). 
 
The exact role of acetaldehyde-protein 
adducts in the pathogenesis of alcohol-
induced diseases has not been fully 
clarified, but several mechanisms have been 
proposed. Acetaldehyde adduct formation 
may alter the structure of the modified 
proteins, and thus interfere with their 
normal cellular functions (Sorrell and 
Tuma, 1987). Acetaldehyde also inhibits 
the function of the human DNA repair 
protein O6-methylguanine transferase both 
in vivo and in vitro, which may occur even 
at nanomolar concentrations (Garro et al., 
1986; Espina et al., 1988). In addition, 
acetaldehyde-protein adducts may be 
recognized as neoantigens by the immune 
system, and in this manner they may trigger 
harmful immune responses (Nicholls et al., 
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1992). Circulating antibodies against 
acetaldehyde-protein adducts have indeed 
been detected in humans (Israel et al., 1986; 
Niemelä et al., 1987). These antibodies may 
contribute to the development and 
progression of liver injury, which suggests 
that immunological mechanisms are also 
involved in the pathogenesis of alcoholic 
liver damage (Tuma and Klassen 1992).  
 
Both exogenous and metabolically derived 
acetaldehyde can bind with gastric mucosal 
proteins in rats (Salmela et al., 1997). This 
has been suggested to be one possible factor 
behind alcohol-associated gastric injury. So 
far, there is no evidence indicating that such 
adduct formation would occur at other sites 
of the digestive tract. Similar adduct 
formation could, however, also take place 
in the oral cavity or colon due to the high 
microbial production of acetaldehyde.   
Acetaldehyde-DNA adducts 
As a highly reactive agent, acetaldehyde 
can form adducts not only with proteins, 
but also with DNA bases (Hemminki and 
Suni, 1984; Vaca et al., 1995). In fact, the 
formation of acetaldehyde-DNA adducts is 
considered to be a critical event in the 
initiation of chemical carcinogenesis in 
alcohol consumers (Vaca et al., 1995). 
Acetaldehyde-DNA adducts have been 
identified in the liver of mice after chronic 
alcohol administration (Fang and Vaca, 
1995). In humans, enhanced formation of 
these adducts has been detected in 
peripheral white blood cells of alcohol 
abusers (Fang and Vaca, 1997). Moreover, 
DNA adducts have been found in the 
colonic mucosa of patients with colorectal 
cancer (Pfohl-Leszkowicz et al., 1995), and 
in human buccal cells exposed to 
acetaldehyde in vitro (Vaca et al., 1998).  
Lipid peroxidation 
Lipid peroxidation is a degradative process 
caused by harmful actions of oxidizing free 
radicals, superoxide and hydroxyl radicals. 
Free radicals are molecules that contain one 
or more unpaired electrons, and thus are 
very reactive with a short half-life. These 
highly reactive molecules can abstract a 
hydrogen atom from a polyunsaturated fatty 
acid, and thereby initiate lipid peroxidation. 
Since lipids are major components of 
biological membranes, peroxidative loss of 
membrane integrity may lead to tissue 
injury (Mufti et al., 1993). Cells are 
normally protected against free radicals by 
glutathione, which is present in all animal 
cells in high concentrations. A severe 
reduction in glutathione levels increases 
lipid peroxidation in vivo (Wendel et al., 
1979). Enhanced lipid peroxidation has 
been proposed to be one of the key 
mechanisms for ethanol-induced liver 
injury (Situnayake et al., 1990). One 
explanation for this could be acetaldehyde’s 
capacity to reduce hepatic glutathione 
levels (Shaw et al., 1981), and so to induce 
lipid peroxidation, as demonstrated in 
isolated perfused livers (Müller and Sies, 
1982). Furthermore, high acetaldehyde 
concentrations administered to rats have 
been reported to result in the formation of 
free radicals in vivo (Reinke et al., 1987). 
Lipid peroxidation products can also react 
with DNA and form adducts with known 
carcinogenicity and miscoding potential 
(Brooks, 1997). Accordingly, lipid 
peroxidation may play a prominent role in 
ethanol-associated carcinogenesis. 
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3. AIMS OF THE STUDY 
Excessive alcohol consumption is associated with an increased risk of cancer of the upper 
digestive tract. However, the pathogenetic mechanisms responsible for the enhanced risk of 
cancer in alcoholics are not completely understood. Many recent studies have suggested that 
ethanol-associated digestive tract cancers might be caused by the local carcinogenic action of 
the first metabolite of ethanol oxidation, acetaldehyde. A lot of research has lately been 
carried out to explore the production and effects of this toxic compound in the digestive tract. 
It is now known that many microbes of the alimentary tract can produce acetaldehyde from 
ethanol in the gut. Acetaldehyde has been shown to be carcinogenic in animals, but so far 
there has not been enough evidence in humans. 
 
The specific aims of this study were: 
 
1. To examine salivary acetaldehyde production from ethanol in subjects with different 
ALDH2 genotypes in order to find evidence for the local carcinogenic action of 
acetaldehyde in humans. 
 
2. To investigate whether it is possible to reduce the local production of acetaldehyde in 
saliva by using 4-methylpyrazole prior to ethanol exposure. 
 
3. To study ethanol metabolism in the hypochlorhydric stomach associated with the use 
of gastric proton pump inhibitors and atrophic gastritis, and to relate the findings to 
changes in gastric microbial flora. 
 
4. To examine further which bacterial species and/or groups are responsible for 
acetaldehyde formation in the hypochlorhydric stomach, and to characterize their 
ADH enzymes.        
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4. MATERIALS AND METHODS 
4.1. ETHICAL CONSIDERATIONS 
All studies were approved by the Ethical 
Committee of the Department of Medicine, 
Helsinki University Central Hospital, and 
an informed consent to participate in the 
study was obtained from the subjects. The 
study with 4-methylpyrazole (II) was also 
approved by the Finnish National Agency 
for Medicines. 
4.2. THE EFFECT OF ALDEHYDE DEHYDROGENASE-2 GENOTYPE 
ON SALIVARY ACETALDEHYDE PRODUCTION (I) 
Subjects 
Twenty subjects of Asian origin took part in 
the study (12 men, 8 women; age range 22-
44 years, mean body weight 60±2 kg). All 
subjects were healthy, and none of them 
had received any antibiotics or used 
antiseptic mouthwashes for four weeks 
preceding the study. All subjects were told 
to refrain from alcohol for at least 36 hours 
before the study. 
Study design 
The studies started between 9.00 and 10.00 
a.m. The volunteers were allowed to eat a 
light breakfast at least 90 minutes before 
the study. A commercially available 
paraffin wax chewing gum (Orion 
Diagnostics, Espoo, Finland) was used to 
stimulate the production of saliva. After 
baseline saliva collection, each volunteer 
ingested 0.5 g ethanol/kg body weight in a 
standardized 10% v/v solution of absolute 
ethanol in orange juice within 20 minutes. 
To remove local ethanol, the subjects rinsed 
their mouths with water, and thereafter the 
saliva samples were taken every 20 minutes  
until the systemic ethanol level returned to 
zero. Salivary acetaldehyde and ethanol 
levels were measured by using headspace 
gas chromatography. Blood samples for 
ALDH2 genotyping and for gas 
chromatographic ethanol and acetaldehyde 
level determinations were taken from an 
antecubital vein 60 minutes after the start of 
alcohol ingestion. 
In vitro and in vivo salivary 
acetaldehyde production 
In vitro salivary acetaldehyde production 
was determined by incubating 400 Zl of
oral saliva with 50 Zl of 22 mM ethanol 
(final concentration) for 90 minutes at 
37°C. The reaction was stopped by 
injecting 50 Zl of 6 M perchloric acid 
(PCA) through the rubber septum of the 
closed vial. To measure in vivo salivary 
acetaldehyde levels, 450 Zl of saliva was 
immediately transferred into a vial 
containing 50 Zl of PCA. Acetaldehyde and 
ethanol levels were analysed by using 
headspace gas chromatography. 
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Determination of blood 
acetaldehyde and ethanol 
Samples for blood acetaldehyde 
measurement were collected into evacuated 
blood collecting tubes containing sodium 
fluoride and potassium oxalate as 
anticoagulants for 3 ml of blood. 
Immediately after sampling, 0.5 ml of 
blood was pipetted into 2 ml of ice-cold 0.6 
M PCA made in saline and instantly 
deproteinized with a whirlimixer. The 
precipitated proteins were spun down by 
centrifugation at 4000 g; thereafter, 500 Zl
of the clear supernatants were transferred 
into glass vials, sealed with Teflon-coated 
rubber stoppers, and analysed by using 
headspace gas chromatography. For the 
measurement of blood ethanol 
concentration, blood was collected into 3 
ml tubes containing ethylenediaminetetra-
acetic acid (EDTA). 500 Zl of blood was 
pipetted into vials, and thereafter blood 
ethanol levels were analysed by using 
headspace gas chromatography. 
ALDH2 genotyping 
ALDH2 genotyping was performed at the 
Institute of Human Genetics, University of 
Hamburg, Hamburg, Germany. Genomic 
deoxyribonucleic acid (DNA) was extracted  
 
from leukocytes isolated from EDTA-
blood. ALDH2 genotyping was carried out 
by using polymerase chain 
reaction/restriction fragment length 
polymorphism (PCR-RFLP) according to 
the method of Harada and Zhang (1993) 
with modifications suggested by Suzuki et 
al. (1994). 1 Zl of genomic DNA was 
mixed with 0.5 Zl (20 pmol) of each primer 
(5´-CAA ATT ACA GGG TCA AGG 
GCT-3´ sense; 5´-CCA CAC TCA CAG 
TTT TCT CTT-3´ antisense) in a total 
volume of 25 Zl containing 0.5 Zl of 10
mM deoxynucleotides (dNTPs), 0.8 Zl of
50 mM MgCl2, 1 unit of Taq DNA 
polymerase, 2.5 Zl of PCR buffer and 19 Zl
of water. Thirty cycles of PCR 
(denaturation at 94°C for 90 sec, annealing 
at 58°C for 180 sec and extension at 72°C
for 60 sec) were performed. Each PCR 
product was digested with the restriction 
enzyme Mbo II for 3-4 hours. Just before 
electrophoresis, the products were 
incubated at 60°C for 5 minutes and chilled 
on ice water. The digest was separated in 
7% polyacrylamide gels under 10 V/cm for 
1 hour. The gel was stained with silver 
nitrate solution as described by Budowle et 
al. (1991), and the genotypes were 
identified on the basis of the size of the 
restriction fragments. 
4.3. PAROTID GLAND CANNULATION STUDY (I) 
Subjects and study design 
Three ALDH2-deficient Asians (males) and 
three Finnish volunteers (one female, two 
males) with normal ALDH2 participated in  
 
the study. All subjects were healthy, they  
had not received any antibiotics or used  
antiseptic mouthwashes for four weeks 
preceding the study, and had not used 
alcohol for at least 36 hours before the study. 
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At the beginning of the study all subjects 
ingested ethanol (0.5g/kg of body weight) 
in orange juice as 10% v/v solution within 
20 minutes. In order to obtain sterile parotid 
gland saliva, the duct of the right parotid 
gland was cannulated with a sialography 
catheter. Parotid gland saliva was collected 
60 to 80 minutes after ethanol ingestion, 
and its ethanol and acetaldehyde 
concentrations were determined by using 
headspace gas chromatography. 
 
4.4. THE EFFECT OF 4-METHYLPYRAZOLE ON ETHANOL 
METABOLISM AND SALIVARY ACETALDEHYDE PRODUCTION (II) 
Subjects 
Five ALDH2-deficient Chinese (two females 
and three males; mean age 31±3 years; mean 
body weight 63±7 kg) and six Finnish 
volunteers (males; mean age 25±2 years; mean 
body weight 78±4 kg) with normal ALDH2 
took part in the study. All subjects were 
moderate alcohol consumers (less than 70 g of 
ethanol per week). Two of the volunteers in 
both groups were light smokers, all others 
were nonsmokers. Other criteria for the study 
were the same as in study I (chapter 4.2.). 
Study Design 
In this study, we had two study days which 
were separated by a 1-week interval. The basic 
study design of the experiments on both study 
days was the same as in study I (chapter 4.2.). 
In the present study, we additionally followed 
the blood pressure, heart rate, and skin 
temperature of the volunteers. A bit lower dose 
of ethanol, 0.4 g/kg body weight, was also 
used. On the second study day, the volunteers 
received 4-methylpyrazole (4-MP) 10-15 
mg/kg body weight orally two hours before 
other experiments. The liquid solution of 4-
MP was specially prepared for the study at the 
Helsinki University Central Hospital 
Pharmacy. 
In vitro and in vivo salivary 
acetaldehyde production 
Salivary acetaldehyde and ethanol levels 
were determined as described in chapter 4.2. 
Determination of blood 
acetaldehyde and ethanol 
Blood acetaldehyde and ethanol were 
measured as described in chapter 4.2.  
Determination of ethanol 
elimination rate 
Salivary ethanol levels, which are known to 
be comparable to blood ethanol levels 
(Jones, 1979), were used in the 
determination of the ethanol elimination 
rate in this study. The concentration-time 
profiles of ethanol were evaluated 
according to zero order kinetics. This 
pharmacokinetic model assumes a 
rectilinear disappearance of ethanol from 
blood after the absorption and distribution 
of the dose is completed. The ethanol 
elimination rate from the body was 
obtained by dividing the dose given (0.4 
g/kg) by the estimated time of reaching zero 
concentration of ethanol in blood. 
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4.5. THE EFFECT OF IATROGENIC HYPOCHLORHYDRIA ON 
INTRAGASTRIC ACETALDEHYDE PRODUCTION (III) 
Subjects 
Eight healthy men, with an age range of 21-
25 years volunteered for the study. Their 
mean body weight was 73±3 kg and body 
mass index 22.7±0.7 kg/m². The subjects 
had not received any antibiotics for four 
weeks prior to the study neither did they 
use any other drugs during the study days. 
One of the volunteers was a light smoker 
and all were normal social drinkers, with an 
average consumption of 90 g or less (range 
40-120 g) of ethanol per week.  
Study design 
A paired study design in which each subject 
served as his own control was used. Two 
study days were separated by a 1-week 
interval. The volunteers fasted for at least 
six hours before the study, and were 
admitted to the Department of 
Gastroenterology, Helsinki University 
Central Hospital, Helsinki, Finland, where 
all studies started between 1.30 and 2.00 
p.m. Ethanol (0.6 g/kg body weight) was 
diluted in water at 15% v/v concentration. 
The volunteers ingested the dose within 20 
minutes, and thereafter stayed on their left 
sides for 40 minutes to avoid total gastric 
emptying. At 60 minutes a paraffin- 
stimulated saliva sample was collected and 
gastroscopy performed. Gastric juice was 
aspirated into collectors immediately after 
the gastroscope (Olympus, GIF-Q140) 
entered the stomach. The pH of the 
obtained gastric juice was determined by 
using a glass electrode and a digital pH 
meter (WTW pH-521, Weilheim, 
Germany), and ethanol and acetaldehyde 
levels were measured by using headspace 
gas chromatography. Part of the gastric 
juice was frozen to -80°C for later 
microbial analysis. During the seven days 
between the experiments, the volunteers 
received 30 mg lansoprazole orally twice a 
day. Experiments were the same on both 
study days, except for routine gastric 
mucosal biopsies, which were only taken 
during the first endoscopy.  
In vivo intragastric and salivary 
acetaldehyde production 
Acetaldehyde and ethanol were measured 
from gastric juice and saliva by using 
headspace gas chromatography as described 
in chapter 4.2.   
Microbial analysis 
The microbiological analyses were 
performed at the Anaerobe Reference 
Laboratory of the National Public Health 
Institute, Helsinki, Finland. The gastric 
juice samples were thawed, and diluted in 
peptone yeast extract broth. An aliquot of 
100 Zl of the undiluted sample and its 100-
fold dilutions were inoculated and spread 
on several selective and non-selective agar 
media for the enumeration and isolation of 
the total counts and main groups of aerobic 
and anaerobic bacteria and yeasts. The 
aerobic plates were incubated at 35°C in an 
atmosphere containing 5% CO2 for up to 
five days; the anaerobic plates were 
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incubated in anaerobic jars which were 
filled by using the evacuation replacement 
method with a gas mixture (90% N2, 5%
CO2, 5% H2) for seven days for the first 
inspection and up to 14 days for the final 
inspection. The bacteria were enumerated 
and identified by using established methods 
(Murray et al., 1995; Summanen et al., 
1993). 
4.6. INTRAGASTRIC ETHANOL METABOLISM IN PATIENTS WITH 
ATROPHIC GASTRITIS (IV) 
In vivo ethanol metabolism in the 
stomach 
Seven patients (one male and six females) 
with achlorhydric atrophic gastritis and five 
healthy subjects (two males and three 
females) volunteered for the study. Six of 
the atrophic gastritis patients had also been 
diagnosed for pernicious anaemia. The 
mean age of the volunteers was 60±3 years 
for the atrophic gastritis patients, and 26±1 
years for the controls. The mean body 
weights were 71±5 kg and 66±3 kg for the 
atrophic gastritis patients and controls, 
respectively. None of the subjects had used 
any antibiotics, proton pump inhibitors or 
histamine-2-receptor antagonists for four 
weeks preceding the study. All volunteers 
were nonsmokers and normal social 
drinkers, with an average consumption of 
70 g or less of ethanol per week. 
 
The volunteers fasted over night before the 
study days, which were separated by a 1-
week interval. The participants were 
admitted to the Department of 
Gastroenterology, Helsinki University 
Central Hospital, Helsinki, Finland, and all 
studies started between 8 and 9 a.m. A 
nasogastric tube (Flocare CH8, Chatel 
Medical Devices SA, Chatel St Denis, 
Switzerland) was placed into the volunteers 
at the beginning of both study days, and the  
stomach was aspirated empty. On the first 
study day, glucose (3 ml/kg body weight) at 
10% v/v solution was infused into the 
stomach of the subjects. On the second day, 
ethanol (0.3 g/kg body weight) diluted in 
water at 15% v/v concentration was used 
instead of glucose. After the infusions the 
volunteers stayed on their left sides to avoid 
total gastric emptying. 15 ml of gastric 
juice was aspirated from each volunteer 
into a collector at 30 and 60 minutes after 
both infusions. Thereafter, the gastric juice 
was transferred into gas chromatograph 
vials, and to cryovials which were frozen to 
-80°C for later microbial analysis. The pH 
of the obtained gastric juice was determined 
by using a glass electrode and a digital pH 
meter. At the end of both study days 5 ml of 
paraffin stimulated saliva was collected 
from each volunteer. 
In vivo intragastric and salivary 
acetaldehyde production 
Acetaldehyde and ethanol were measured 
from gastric juice and saliva immediately 
after sampling by using headspace gas 
chromatography as described in chapter 4.2.   
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Microbial analysis 
The microbial analysis of the gastric juice 
and salivary samples was carried out as 
described in chapter 4.5. 
In vitro intragastric acetaldehyde 
production 
Samples of gastric juice were collected 
during elective upper gastrointestinal 
endoscopy from patients with different 
gastrointestinal diseases. Based on 
histological mucosal findings, 16 patients, 
five males and 11 females, mean age 49±2 
years, had normal gastroduodenal mucosa, 
and 14 patients, six males and eight 
females, mean age 53±2 years, had chronic 
atrophic corpus gastritis. Patients using 
histamine-2-receptor antagonists or proton 
pump inhibitors were not included in the 
study. All subjects had fasted for at least 8 
hours prior to the upper gastrointestinal 
endoscopy during which gastric juice was 
aspirated via endoscope. Due to the limited 
volume of gastric juice in some patients 
with corpus atrophy, a small amount of 
water was infused into the stomach before 
aspiration. The collected samples were 
stored refrigerated in sealed vials at +4°C 
for up to 20 hours until acetaldehyde 
analysis was performed. The pH of the 
samples was determined by using a glass 
electrode and a digital pH meter. 
 
In vitro acetaldehyde production was 
studied by incubating 450 µl of the gastric 
juice with 50 µl of 1 M potassium 
phosphate buffer (pH 7.4) with or without 
ethanol (final concentration 1%) in sealed 
vials at 37°C for two hours. Acetaldehyde 
concentration was determined by using 
headspace gas chromatography. 
 
4.7. ACETALDEHYDE PRODUCTION AND ALCOHOL 
DEHYDROGENASE CHARACTERISTICS OF AEROBIC GASTRIC 
BACTERIA (V) 
Bacterial samples 
Pure cultures of the aerobic bacteria 
isolated in study III (chapter 4.5) from 
hypochlorhydric gastric juices were used in 
this study. These bacterial samples, which 
had been frozen at –70°C after the isolation 
and identification of the bacteria, were 
revived on blood agar media. The cultures 
were then harvested into centrifuge tubes 
with 100 mM potassium phosphate buffer  
 
(pH 7.4) and washed with the buffer three  
times before bacterial suspensions, the 
turbidity of which had been adjusted to 
correspond to McFarland standard 3 (9 x 
108 colony-forming units (cfu)/ml) for 
acetaldehyde and 6 (1.8 x 109 cfu/ml) for 
ADH activity determinations, were 
prepared. The actual number of viable 
bacteria, expressed as cfu/ml in the vials, 
was determined by quantitative bacterial 
culture. 
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Measurement of acetaldehyde 
production 
The ability of different bacteria to produce 
acetaldehyde in vitro was determined by 
incubating 400 Zl of the intact bacterial 
suspension in closed headspace vials with 
50 Zl of 100 mM potassium phosphate 
buffer (pH 7.4) containing ethanol (final 
concentration 22 mM) for 60 minutes at 
37°C. The reactions were stopped by 
injecting 50 Zl of 6 M perchloric acid 
(PCA) through the rubber septum of the 
vial, whereafter acetaldehyde was analysed 
by using headspace gas chromatography. 
The effect of different incubation times and 
ethanol and bacterial concentrations on 
acetaldehyde production was also studied 
by varying these parameters. 
Measurement of ADH activity 
An aliquot of the bacterial suspension was 
sonicated 8 x 20 sec in an ice bath and then 
centrifuged at 100,000 x g at 5°C for 65 
minutes to obtain cytosol. Cytosolic ADH 
activities were determined spectrophoto-
metrically, after addition of ethanol, by 
measuring the reduction of NAD (final 
concentration in the reaction mixture 1 
mM) at 340 nm at 25°C in 100 mM glycine 
buffer (pH 9.6) containing 2 ZM of
rotenone, with ethanol concentrations 
ranging from 0.15 mM to 5 M. Enzyme 
activities were related to the protein 
concentrations of the supernatants, which 
were determined by using the Bio-Rad 
protein assay (Hercules, CA, USA).  
 
4.8. GAS CHROMATOGRAPHIC MEASUREMENTS OF ETHANOL AND 
ACETALDEHYDE 
Acetaldehyde production from ethanol 
for all studies was analysed by using 
headspace gas chromatography in which 
the vials were heated to a temperature of 
37°C or 65°C (blood acetaldehyde 
determination, studies I, II), as reported 
earlier (Eriksson et al., 1982; Pikkarainen 
et al., 1979). The conditions for analysis 
were: Column 60/80 Carbopack B/5% 
Carbowax 20M, 2 m x 1/8” (Supelco Inc, 
Bellefonte, USA); oven temperature, 
85°C; transfer line and detector 
temperature, 200°C; carrier gas flow rate 
(N2), 20 ml/min. 
 
An artifactual production of acetaldehyde 
from ethanol prior to headspace analysis is 
a problem associated with the measurement 
of acetaldehyde in biological fluids 
(Eriksson end Funaka, 1993). To control for 
this non-enzymatic artifactual acetaldehyde 
formation from ethanol during protein 
precipitation, perchloric acid was added 
simultaneously with ethanol into additional 
vials which were not incubated. The 
acetaldehyde concentrations of these 
control samples were subtracted from the 
acetaldehyde values obtained from the 
samples after the incubation periods (I-V). 
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4.9. STATISTICAL ANALYSIS 
The results are expressed as means (V) or 
as mean ± SEM (I-IV). The statistical 
differences between the study groups were 
analysed by using Student’s t test (I, II, IV), 
and the differences with and without the 
medications by using paired t test (II, III). 
Logarithmic transformation was performed 
when appropriate. The possible correlations 
were tested by using linear regression  
 
analysis (I, II) or Spearman Rank Order 
Correlation (III, V). Fisher’s exact test was 
used to find out possible differences in 
confounding factors between the study 
groups (I). Values for Km (Michaelis 
constant) were determined by using 
Lineweaver-Burk plots with a computerized 
data-analysis program (V).   
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5. RESULTS 
5.1. THE EFFECT OF ALDEHYDE DEHYDROGENASE-2 GENOTYPE 
ON SALIVARY ACETALDEHYDE PRODUCTION (I) 
ALDH2 genotyping showed that seven of 
the Asian volunteers were heterozygous 
for the mutant ALDH2*2 allele 
(ALDH2*2/ALDH2*1) and thirteen had the 
normal ALDH2*1/ALDH2*1 genotype. The 
groups did not differ with respect to gender, 
age, mean weight, smoking habits or 
alcohol consumption. 
 
The mean in vivo salivary acetaldehyde 
levels were two to three times higher  
(p<0.001) in the ALDH2-deficient 
volunteers than in the subjects with normal  
ALDH2 throughout the whole follow-up  
 
period of 240 minutes (Fig. 1). Although 
the salivary ethanol levels were slightly 
higher in the subjects with the mutant 
ALDH2*2 allele, the difference between the 
study groups was not statistically 
significant. The salivary acetaldehyde and 
ethanol levels correlated highly 
significantly (p<0.001) in both study 
groups. The mean capacity of the oral 
saliva to produce acetaldehyde from ethanol 
in vitro during the 90-minute incubation 
was equal in both groups; 86.2±6.5 ZM and 
84.1±13.1 ZM for subjects with and without 
the ALDH2*2 allele, respectively.  
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Fig. 1. In vivo acetaldehyde levels in oral saliva in seven subjects 
with the ALDH2*2 allele and in 13 subjects with normal ALDH2 
after a moderate dose of alcohol (0.5 g/kg of body weight).
(Reproduced with permission from Lippincott Williams & Wilkins).  
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The mean acetaldehyde levels in the blood 
at 60 minutes were 6.6±2.6 ZM in the 
ALDH2-deficient subjects and 0.3±0.2 ZM
in the subjects with normal ALDH2 
(p=0.003). The mean blood ethanol levels 
at the same time were 12.3±1.3 mM and 
10.9±0.5 mM for volunteers with and 
without the ALDH2*2 allele, respectively 
(nonsignificant). The mean blood 
acetaldehyde level of the ALDH2-deficient 
volunteers at 60 minutes was only one ninth 
of the acetaldehyde level in the saliva in 
vivo.
Sixty minutes after the dose of alcohol, all 
three Asian subjects with the ALDH2*2 
allele had markedly elevated acetaldehyde 
levels in their sterile parotid gland saliva 
samples, whereas there was no measurable 
acetaldehyde in the parotid gland saliva 
samples of any of the Caucasians with the 
normal ALDH2 genotype (Table 1).  
 
Table 1. Parotid gland saliva in three subjects with and without the 
ALDH2*2 allele 60 to 80 minutes after a moderate dose of alcohol 
(0.5 g/kg of body weight). 
 
Acetaldehyde      Ethanol   
(ZM)    (mM)  
Subjects with ALDH2*2 
Case 1        75.0      8.8 
 Case 2        21.8      3.4   
 Case 3          3.9      9.9 
Subjects without ALDH2*2 
 Case 1       not detectable     6.2 
 Case 2       not detectable   13.9 
 Case 3       not detectable   13.2 
5.2. THE EFFECT OF 4-METHYLPYRAZOLE ON ETHANOL 
METABOLISM AND SALIVARY ACETALDEHYDE PRODUCTION (II) 
As expected, 4-MP decreased the ethanol 
elimination rate in both study groups, the 
reduction being 38 % in ALDH2-deficient 
volunteers and 46 % in subjects with 
normal ALDH2. The reduced ethanol 
elimination rate was also demonstrated by 
significant rises in the mean blood and 
salivary ethanol levels at 60 minutes in both 
study groups. The mean blood acetaldehyde 
levels at 60 minutes decreased in ALDH2-
deficient subjects from 6.7±1.4 ZM to 
0.8±0.4 ZM, p=0.013, but remained under 
the detection limit in subjects with normal 
ALDH2 on both study days.  
 
Without 4-MP, the mean in vivo salivary 
acetaldehyde levels were approximately 1.5 
times higher in ALDH2-deficient 
volunteers than in subjects with normal 
ALDH2 (Fig. 2). The difference between 
the groups disappeared, however, when 4-
MP was used before ethanol administration 
(Fig. 2). The highest peak in the mean 
salivary acetaldehyde production in 
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subjects with the ALDH2*2 allele at 40 
minutes dropped significantly by using 4-
MP, from 47.9±5.5 ZM to 34.4±3.1 ZM, 
p=0.035. At that time point there was no 
difference between the mean salivary 
ethanol levels with and without the 
medicine (11.9±1.5 mM without and 
12.6±1.2 mM with 4-MP, nonsignificant). 
A marked reduction in the salivary 
acetaldehyde production with 4-MP in 
ALDH2-deficient subjects was found when 
the mean in vivo salivary acetaldehyde 
levels were expressed at different ethanol 
concentrations, whereas the medication did 
not have any effect on the salivary 
acetaldehyde production in the subjects 
with normal ALDH2 (Fig. 2). The 
correlations between individual salivary 
acetaldehyde and ethanol levels were 
positive and highly significant (r values 
ranged from 0.928 to 0.995 and all p values 
were less than 0.001) both with and without 
4-MP in both groups. 4-MP did not change 
the mean in vitro salivary acetaldehyde 
production from ethanol in either of the 
study groups.  
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Fig. 2. The effect of 4-MP on the mean salivary acetaldehyde levels 
at certain ethanol concentrations in five ALDH2-deficient subjects 
and six subjects with normal ALDH2. *p<0.05 ALDH2-deficient 
volunteers with and without 4-MP. (Reproduced with permission).  
Treatment with 4-MP markedly suppressed 
the flushing response of the ALDH2-
deficient volunteers. The raises in heart rate 
and skin temperature as well as the drop in 
diastolic blood pressure disappeared when 
4-MP was used before ethanol ingestion. In 
subjects with the normal ALDH2 genotype 
there was no change in these parameters.  
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5.3. THE EFFECT OF IATROGENIC HYPOCHLORHYDRIA ON 
INTRAGASTRIC ACETALDEHYDE PRODUCTION (III) 
The mean pH level of the gastric juice rose 
from 1.3±0.06 to 6.1±0.5, p<0.001 with 
lansoprazole treatment. After alcohol 
administration, this was associated with a 
significant increase in the mean intragastric 
acetaldehyde level from 22.1±2.3 ZM to 
55.4±8.0 ZM, p=0.003. The intragastric 
acetaldehyde levels increased in all 
volunteers during the medication; the  
 
highest measured level was 100.5 ZM (Fig. 
3). The mean ethanol concentration of the 
gastric juice was 1.7% (range 0.7-3.4%) 
and 2.6% (range 1.2-4.1%), p=0.054, 
nonsignificant, before and during the 
treatment, respectively. Lansoprazole did 
not change the mean salivary acetaldehyde 
level (44.7±6.8 ZM before the medication 
and 36.1±6.4ZM during it). 
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Fig. 3. The effect of lansoprazole treatment on gastric juice acetaldehyde 
concentrations in eight volunteers after ethanol (0.6 g/kg of body weight) 
ingestion. (Reproduced with permission from Aliment Pharmacol Ther).  
Before the medication, minor growth of 
aerobic bacteria was detected in the gastric 
juice of two volunteers, 1 x 101 and 2 x 101
cfu/ml, respectively; the other bacterial 
cultures were negative. During lansoprazole, 
the mean total bacterial counts were 1.3±0.7 
x 106 cfu/ml for aerobes and 1.5±0.8 x 106
cfu/ml for anaerobes. The increase in both 
total counts was highly significant 
(p<0.001). The cultures of yeasts were 
negative both before and during lansoprazole 
treatment. A vast selection of oral bacterial 
species was present; Table 2 summarizes the 
bacteriological results. There was also a 
highly significant positive correlation 
(r=0.90, p<0.001) between the individual 
total aerobic bacterial counts and the 
individual gastric juice acetaldehyde levels 
during the medication. The correlation 
between individual acetaldehyde levels and 
anaerobic bacterial counts was also positive 
(r=0.76, p=0.021). 
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Histologically, the gastric mucosal biopsies 
were within normal limits in all of the 
volunteers, and all of them were 
Helicobacter pylori-negative. 
 
Table 2. The effect of lansoprazole treatment on the mean gastric juice bacterial counts (cfu/ml) 
in eight volunteers.  
Before    During    Prevalence 
 lansoprazole  lansoprazole 
Aerobes 
Total counts                                  negative*   1.3 x 106
Stomatococci spp.        negative   1.4 x 105 8/8  
 Viridans group Streptococci  negative   1.0 x 106 7/8  
 Neisseria spp.  negative   1.3 x 104 7/8  
 Corynebacterium spp.  negative   4.8 x 103 4/8  
 Staphylococcus aureus   negative   6.8 x 101 4/8  
 Coagulase-negative Staphylococci 
 and Micrococci spp.  negative   1.0 x 103 1/8  
 Haemophilus parainfluenzae  negative   6.3 x 103 1/8  
 Bacillus spp.  negative   3.8 x 103 1/8  
Anaerobes 
Total counts  negative   1.5 x 106
Pigmented Prevotella spp.  negative   1.3 x 105 6/8  
 Actinomyces spp.  negative   5.5 x 104 6/8  
 Fusobacterium spp.  negative   1.0 x 104 5/8  
 Bacteroides ureolyticus-like group     negative   5.1 x 103 4/8  
 Lactobacillus spp.  negative   1.4 x 105 3/8  
 Nonpigmented Prevotella spp.  negative   1.4 x 104 2/8  
Anaerobic cocci  negative   2.8 x 105 2/8  
 Capnocytophaga spp.  negative   3.4 x 101 1/8  
* Detection threshold 101 cfu/ml 
 
5.4. INTRAGASTRIC ETHANOL METABOLISM IN PATIENTS WITH 
ATROPHIC GASTRITIS (IV) 
Endogenous ethanol and acetaldehyde production 
The mean pH levels of the gastric juice of 
the in vivo study groups were 6.8±0.3 and 
1.6±0.2 in atrophic gastritis patients and 
controls, respectively. Some endogenous 
intragastric ethanol production after glucose 
infusion was detected in four of the subjects 
with atrophic gastritis, whereas no 
endogenous ethanol was measured from the 
gastric juices of the control subjects. The 
mean ethanol levels and corresponding 
mean acetaldehyde levels of the gastric 
juice after intragastric glucose infusion in 
atrophic gastritis patients are summarized in 
table I, study IV. 
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In vivo acetaldehyde production from ethanol 
After intragastric ethanol infusion, the 
mean acetaldehyde levels in the gastric 
juice of the study groups were 44.5±9.2 µM 
in atrophic gastritis patients vs. 9.8±0.9 µM 
in controls at 30 minutes and 33.7±7.9 µM 
vs. 5.1±1.5 µM at 60 minutes (Fig. 4). The 
difference between the study groups was 
4.5-fold at 30 minutes (p=0.011) and 6.5-
fold (p=0.01) at 60 minutes (Fig. 4). The 
mean ethanol concentrations of the gastric 
juice at 30 and 60 minutes were 2.8% 
(range 0.2-5.1%) and 1.5% (range 0.1-
4.2%) in atrophic gastritis patients, and 
4.3% (range 0.7-5.1%) and 0.8% (range 
0.04-1.8%) in controls. The differences in 
gastric juice ethanol concentrations 
between the study groups were not 
statistically significant. Neither did the 
groups differ in their in vivo salivary 
acetaldehyde production; the mean salivary 
acetaldehyde levels at 60 minutes were 
16.0±2.1 µM and 17.3±1.9 µM in atrophic 
gastritis patients and in controls, 
respectively.
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Fig. 4. The mean gastric juice acetaldehyde levels at 30 and 60 min after 
intragastric ethanol (0.3 g/kg of body weight) infusion in seven atrophic 
gastritis patients and five controls. *p<0.05 patients compared to controls. 
(Reproduced with permission from Scand J Gastroenterol).  
Microbial analysis 
Microbial analysis showed marked growth of 
both aerobic and anaerobic bacteria in the 
gastric juice of the atrophic gastritis patients, 
whereas only minor growth of anaerobic 
bacteria, 4.6 x 102 cfu/ml at 30 minutes and 
2.0 x 101 cfu/ml at 60 minutes, was detected 
in one of the control subjects after ethanol 
infusion. The differences in bacterial counts 
between the study groups were highly 
significant (p<0.001) at all studied time 
points after both infusions. Most patients had 
a positive gastric juice culture for 
Enterobacteriaceae or yeasts on one or more 
sampling occasions; 2/7 of the patients 
harboured both groups. The most prevalent 
and numerous bacterial species were 
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Streptococcus, Stomatococcus, Neisseria, and 
Corynebacterium species of aerobes, and 
Prevotella, Actinomyces, Fusobacterium, and 
Capnocytophaga species of anaerobes. There 
were no significant changes in the 
composition of the gastric flora at 30 and 60 
minutes after both ethanol and glucose 
infusions in the atrophic gastritis patients. 
However, the number of total anaerobes and 
Prevotella species was markedly higher 
(p<0.05) after glucose infusion compared to 
that after ethanol infusion. The microbial 
findings in the saliva were fairly similar in 
both study groups on both study days. 
In vitro acetaldehyde production from ethanol 
In vitro the achlorhydric, pH 6.7±0.2, 
gastric juice of the 14 atrophic gastritis 
patients produced very high acetaldehyde 
levels (maximum 694 µM) during the 
incubation with 1% ethanol. The mean 
acetaldehyde production was 7.6-fold 
higher (p<0.001) in this group than in the 
control group consisting of 16 subjects with 
histologically normal gastroduodenal 
mucosa and acidic gastric juice, pH 
1.9±0.2. The mean acetaldehyde levels 
were 228±52 µM and 30±11 µM in 
atrophic gastritis patients and in controls, 
respectively (Fig. 2, study IV).  
5.5. ACETALDEHYDE PRODUCTION AND ALCOHOL DEHYDROGENASE 
CHARACTERISTICS OF AEROBIC GASTRIC BACTERIA (V) 
Altogether, 11 different aerobic bacterial 
species and 51 different strains were 
isolated from the hypochlorhydric gastric 
juices of the eight volunteers. The number 
of bacterial species or groups from one 
individual varied between one and 11. The 
in vitro acetaldehyde production of the 
isolated bacterial strains varied from less 
than one to 13,687 nmol acetaldehyde/109
cfu/hour. The acetaldehyde production 
capacity of the bacteria was in proportion to 
the length of the incubation time, the 
concentration of bacteria, and the 
concentration of ethanol.  
 
From the 51 strains tested for their 
acetaldehyde production capacity, the strains 
that produced more than 100 nmol 
acetaldehyde/109 cfu/hour (n=23) were  
 
selected for ADH activity measurements. 
Exact Km values for ethanol for 18 of the 
bacterial strains tested for ADH activity 
were obtained. The ADH activities of the 
strains varied from 3.9 to 1253 nmol 
NADH/min/mg protein, and Km´s for 
ethanol ranged from 0.65 to 116 mM and 
from 0.5 to 3.1 M (high Km). A statistically 
significant correlation (r=0.64, p<0.001) 
could be found between the acetaldehyde 
production and the ADH activity of the 
tested strains. The most potent acetaldehyde 
producers according to their acetaldehyde 
production, ADH activity, and Km values for 
ethanol were Neisseria and Rothia species 
and Streptococcus salivarius, whereas nearly 
all Stomatococcus, Staphylococcus, and 
other Streptococcus species had very low 
capacities to produce acetaldehyde. 
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6. DISCUSSION 
6.1. HIGH SALIVARY ACETALDEHYDE IN ALDEHYDE 
DEHYDROGENASE-2-DEFICIENT SUBJECTS: STRONG EVIDENCE FOR 
THE LOCAL CARCINOGENIC ACTION OF ACETALDEHYDE 
Many epidemiological studies show that the 
risk of digestive tract and especially upper 
digestive tract cancers is markedly 
increased in ALDH2-deficient heavy 
drinkers (Murata et al., 1999; Tanabe et al., 
1999; Yokoyama et al., 1996a-c, 1998a,b). 
ALDH2 deficiency is very common in 
certain Asian populations; 30-50% of 
Asians are known to be carriers of the 
mutated ALDH2*2 allele (Goedde et al., 
1992). So far, the observed ethanol-related 
cancer risk among these individuals has 
been hypothesized to originate from the 
systemic effects of elevated blood 
acetaldehyde concentrations (Yokoyama et 
al., 1996b). 
 
In this study, we demonstrated that after a 
moderate dose of alcohol ALDH2-deficient 
subjects have two to three times higher 
acetaldehyde levels in their saliva than 
subjects with normal ALDH2. Since the 
blood acetaldehyde levels of the ALDH2-
deficient volunteers were only one ninth of 
those in the saliva at the same time, the 
higher salivary acetaldehyde levels in these 
individuals cannot be derived from the 
blood. Subsequently, we found out for the 
first time that human parotid salivary 
glands are able to oxidize ethanol to 
acetaldehyde. However, the parotid glands 
of the ALDH2-deficient subjects did not 
appear to have a sufficient capacity to 
metabolize acetaldehyde further to acetate. 
Therefore, acetaldehyde as a very water-
soluble compound diffuses together with 
ethanol into the saliva causing a marked 
increase in the acetaldehyde concentration 
of the mouth. 
 
In accordance with our earlier findings 
(Homann et al., 1997a), this study confirmed 
that salivary acetaldehyde levels correlate 
positively and highly significantly with 
salivary and blood ethanol levels both in 
individuals with normal and in individuals 
with deficient ALDH2. Salivary acetalde-
hyde production in Caucasians with normal 
ALDH2 is mainly of microbial origin and it 
is strongly influenced by individual factors 
(Homann et al., 1997a). Tobacco smoking 
and alcohol drinking, the most potent 
external risk factors for upper digestive tract 
cancers, are the strongest factors increasing 
the microbial acetaldehyde production from 
ethanol (Homann et al., 2000a). Thus, it is 
likely that an ALDH2-deficient individual 
who smokes and drinks heavily produces 
very high levels of acetaldehyde in the oral 
cavity during alcohol consumption. The 
salivary samples of the volunteers with and 
without the mutant ALDH2*2 allele did not 
differ with respect to their capacity to 
produce acetaldehyde from ethanol in vitro.
This suggests that there are no major 
differences regarding this feature in the 
composition of the oral microflora between 
these two groups. 
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The present study with Asian volunteers 
representing different ALDH2 genotypes 
showed that individuals with the mutant 
ALDH2*2 allele have significantly higher 
in vivo acetaldehyde levels in their saliva 
after alcohol consumption than subjects 
with normal ALDH2. Together with earlier 
epidemiological findings these results 
suggest that enhanced alcohol-related 
cancers in ALDH2-deficient subjects 
originate from the local production of 
acetaldehyde in the digestive tract. 
6.2. THE EFFECT OF 4-METHYLPYRAZOLE ON ETHANOL 
METABOLISM AND SALIVARY ACETALDEHYDE PRODUCTION 
As already stated in chapter 2.4., 4-MP 
decreases the rate of ethanol elimination by 
inhibiting ADH competitively (Li and 
Theorell, 1969; Salaspuro, 1985). It can be 
used in the treatment of methanol and 
ethylene glycol poisonings (Jacobsen and 
McMartin, 1997; Jacobsen et al., 1988, 
1990), and in the management of the 
disulfiram-alcohol reaction (Lindros et al., 
1981) and the so-called flushing reaction of 
ALDH2-deficient individuals (Inoue et al., 
1985). In these subjects, even a very small 
dose of alcohol causes marked 
cardiocirculatory stimulation with facial 
flushing, increased heart rate and decreased 
blood pressure (Kupari et al., 1983). Blood 
acetaldehyde levels, which during alcohol 
consumption are about six times higher in 
subjects with partially inactive ALDH2 
than those in subjects with normal ALDH2 
(Yokoyama et al., 1996a), can also be 
reduced by the use of 4-MP (Inoue et al., 
1985). In accordance with these studies, all 
the unpleasant physiological effects as well 
as the blood acetaldehyde levels were also 
markedly suppressed in the present study 
with the oral pre-treatment with 4-MP. 
In this study, the oral dose of 4-MP, before 
ethanol administration, reduced the salivary 
acetaldehyde production significantly in 
ALDH2-deficient subjects, but did not have 
any effect on the salivary acetaldehyde levels 
in subjects with normal ALDH2. As 4-MP is 
an effective inhibitor of human ADHs, but a 
poor inhibitor of bacterial ADHs (Jokelainen 
et al., 1994), these results suggest that 
salivary acetaldehyde production is mainly of 
bacterial origin in individuals with normal 
ALDH2, which supports earlier findings 
(Homann et al., 1997a). Since 4-MP did not 
decrease salivary acetaldehyde levels in 
subjects with the normal ALDH2 genotype, 
these results, in addition, suggest that the role 
of oral mucosal ADHs in salivary 
acetaldehyde production is minimal.  
 
The findings of study I concerning both in 
vivo and in vitro salivary acetaldehyde 
production were also confirmed by this study. 
The in vivo salivary acetaldehyde levels were 
significantly higher in subjects with the 
mutant ALDH2*2 allele than in subjects 
without it, although the ethanol dose used in 
this study was lower than that in the first 
study. The in vitro salivary acetaldehyde 
production from ethanol was again equal in 
both study groups, which indicates that the 
composition of the oral microflora must have 
been fairly similar in these groups. 
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6.3. ETHANOL METABOLISM IN HYPOCHLORHYDRIC STOMACH 
Due to its acidity, the stomach is usually 
sterile, but if the gastric pH rises over 5, 
microbial proliferation can be expected to 
occur in the stomach (Stockbruegger, 
1985). Consequently, gastric microbial 
overgrowth is a common finding in 
achlorhydric atrophic gastritis and 
pernicious anaemia (Drasar et al., 1969; 
Stockbruegger et al., 1984), and during the 
use of gastric proton pump inhibitors or 
histamine-2-receptor antagonists (Thorens 
et al., 1996; Verdu et al., 1994).  
 
Bacterial overgrowth and yeast infection 
are responsible for the endogenous ethanol 
production in the upper digestive tract via 
alcoholic fermentation carried out by 
microbial alcohol dehydrogenases (Bode et 
al., 1984b). Under aerobic and 
microaerobic conditions, and in the 
presence of exogenous ethanol, the ADH-
mediated reaction can also run in the 
opposite direction and result in high local 
acetaldehyde production (Homann et al., 
1997a; Jokelainen et al., 1996c; Salaspuro 
et al., 1999). 
 
Atrophic gastritis has long been recognized 
as a risk factor for gastric cancer. 
Epidemiological follow-up studies have 
shown that the incidence of gastric cancer 
in patients with atrophic gastritis is about 
4.6-10%, and approximately 20-40% of the 
gastric cancer cases are associated with 
atrophic gastritis (Morson et al., 1980; Siurala 
et al., 1974; Testoni et al., 1987; Walker et 
al., 1971). The risk of gastric cancer is 
exponentially correlated with the severity of 
the atrophy (Sipponen et al., 1985). 
Heavy drinkers are also known to have 
more chronic gastritis than moderate 
drinkers (Dinoso et al., 1972; Parl et al., 
1979). Furthermore, their evolution from 
superficial to atrophic gastritis occurs at an 
earlier age and they have more intestinal 
metaplasia than moderate alcohol 
consumers (Parl et al., 1979). It is clear that 
alcohol consumption is one of the major 
risk factors for upper digestive tract cancers 
(IARC, 1988). Nevertheless, the 
epidemiological data concerning the role of 
alcohol drinking in gastric carcinogenesis 
has been very controversial (Doll et al., 
1999). However, the increased risk of 
stomach cancer has been reported to be 
associated with excessive drinking and the 
presence of the mutant ALDH2*2 allele 
(Yokoyama et al., 1998a). 
 
Study III showed that treatment with proton 
pump inhibitors leads to microbial 
colonization of the stomach and to a 2.5-
fold increase in the gastric juice 
acetaldehyde levels after alcohol 
consumption. It can thereby be concluded 
that iatrogenic hypochlorhydria in the 
stomach leads to intragastric microbial 
acetaldehyde production from ingested 
ethanol in healthy volunteers. Moreover, a 
highly significant positive correlation 
between the individual total aerobic 
bacterial counts and the individual 
acetaldehyde levels during the medication 
was found in the study. Study IV 
demonstrated that microbial acetaldehyde 
formation also exists in the stomach of 
patients with achlorhydric atrophic gastritis. 
The acetaldehyde levels after intragastric 
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ethanol infusion in the gastric juice of the 
atrophic gastritis patients were 4.5-6.5–fold 
higher than those in controls. After 2 hours’ 
in vitro incubation with ethanol, the 
difference in the acetaldehyde production of 
the gastric juice between atrophic gastritis 
patients and individuals with normal gastric 
mucosa was even more obvious, 7.6-fold. 
We also managed to detect minor 
endogenous ethanol production in the 
stomach of the atrophic gastritis patients 
after intragastric glucose infusion. In 
addition, the salivary acetaldehyde levels 
measured in these studies after alcohol 
ingestion or infusion correspond to those 
reported earlier (Homann et al., 1997a).  
 
Both studies confirmed the finding that the 
oral cavity is the primary source of the 
microbial flora of the neutral stomach 
(Drasar et al., 1969; Hill, 1995). However, 
the present work additionally showed that 
Enterobacteriaceae and yeasts, well-known 
acetaldehyde producers (Jokelainen et al., 
1996a; Tillonen et al., 1999a), are 
overrepresented in the gastric juice samples 
of patients with atrophic gastritis. The 
composition of the microbial flora in the 
saliva and in the gastric juice of the 
atrophic gastritis patients was very similar. 
The most numerous and prevalent aerobic 
bacterial species isolated from 
hypochlorhydric gastric juices in both 
studies were Streptococcus, Stomatococcus,
Neisseria and Corynebacterium species, 
which is in accordance with earlier studies 
(Thorens et al., 1996; Verdu et al., 1994). 
 
An interesting observation is that the gastric 
juice acetaldehyde levels found in these 
studies were equal to the salivary 
acetaldehyde levels found in ALDH2-
deficient subjects after a moderate dose of 
alcohol (I, II). Moreover, many of the in 
vitro and animal studies dealing with the 
carcinogenic action of acetaldehyde have 
been carried out with acetaldehyde 
concentrations less than 500 ZM (Homann 
et al., 1997b; Koivisto and Salaspuro, 1997, 
1998). Thus, the intragastric acetaldehyde 
levels reported in these studies can be 
considered to be comparable to those 
suggested to be carcinogenic in other 
studies. 
6.4. ACETALDEHYDE PRODUCTION AND ALCOHOL 
DEHYDROGENASE CHARACTERISTICS OF AEROBIC GASTRIC 
BACTERIA 
As described in the previous chapter, 
acetaldehyde formation from ethanol occurs 
in the hypochlorhydric stomach by 
microbes mainly originating from the oral 
cavity. Our earlier studies have shown that 
some oral Candida albicans strains have a 
marked capacity to produce acetaldehyde 
(Tillonen et al., 1999a), but the role of other 
microbial species originating from the 
mouth in the production of ethanol-derived 
acetaldehyde had not been assessed before.  
 
Marked differences in the capacity of 
aerobic gastric bacteria to produce 
carcinogenic acetaldehyde from ethanol 
were found in this study. The most potent 
acetaldehyde producers of the studied 
strains, according to their ADH activity, 
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Km’s for ethanol, and in vitro capacity to 
produce acetaldehyde from ethanol, were 
Neisseria and Rothia species and 
Streptococcus salivarius. A significant 
correlation between bacterial ADH activity 
and in vitro acetaldehyde production from 
ethanol by homologous strains was also 
found. Accordingly, Neisseria and Rothia 
species and Streptococcus salivarius had the 
highest ADH activities, and thereby, the 
highest capacities to produce acetaldehyde, 
whereas Stomatococcus, Staphylococcus and 
other Streptococcus species, which had low 
ADH activities, also produced minimal 
amounts of acetaldehyde. Many bacterial 
strains, especially Neisseria and Rothia 
species, had rather low Km values for 
ethanol. These Km values are comparable 
with the ethanol concentrations that are 
observed in the stomach after normal social 
drinking. Under these circumstances 
bacterial ADHs are able to metabolize 
ethanol to acetaldehyde with a velocity close 
to the maximum, and to produce marked 
amounts of acetaldehyde. The bacteria that 
had the lowest Km values, practically less than 
5 mM, are also most probably able to produce 
acetaldehyde from ethanol that reaches the 
stomach through blood circulation. 
Study III showed that there is a highly 
significant correlation between the number 
of aerobic bacteria and the production of 
acetaldehyde from ingested ethanol in the 
hypochlorhydric stomach. The most 
prevalent and numerous aerobic bacteria 
isolated from the gastric juices in the same 
study were Stomatococcus, Streptococcus 
and Neisseria species. Although Rothia 
species of the present study were potent 
acetaldehyde producers according to their 
high in vitro acetaldehyde production and 
ADH activity, their role in the in vivo 
acetaldehyde production is most probably 
minimal since both the prevalence and the 
number of Rothia species were low in the in 
vivo study. On the other hand, Neisseria 
and Streptococcus salivarius species were 
both very prevalent and numerous and, in 
addition to high ADH activities and 
capacities to produce acetaldehyde from 
ethanol in vitro, they also had low Km
values. Thereby, it can be assumed that 
these bacterial species are probably also 
responsible for the major proportion of the 
in vivo acetaldehyde production in subjects 
with hypochlorhydric stomach.  
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7. SUMMARY AND CONCLUSIONS 
The key findings of the present study were: 
 
1. ALDH2-deficient subjects have two to 
three times higher in vivo salivary 
acetaldehyde levels than subjects with 
normal ALDH2 after a moderate dose of 
alcohol. Part of their “extra” acetaldehyde 
originated from parotid salivary glands, 
which indicates that in addition to oral 
microflora, parotid salivary glands may also 
produce acetaldehyde into saliva. When this 
information is combined with earlier 
epidemiological data reporting an increased 
upper digestive tract cancer risk in heavy- 
drinking ALDH2-deficient individuals, our 
results provide strong evidence that 
acetaldehyde produced from ethanol via 
microbes, mucosal cells and/or glands is a 
local and topical carcinogen in the digestive 
tract in humans.  
 
2. A single dose of 4-MP before ethanol 
ingestion reduces the flushing reaction, and 
both blood and salivary acetaldehyde levels 
in ALDH2-deficient subjects, but not in 
subjects with the normal ALDH2 genotype. 
Since 4-MP is an effective inhibitor of 
human ADHs, but a poor inhibitor of 
bacterial ADHs, these results indicate that 
the role of oral mucosal ADHs in salivary 
acetaldehyde production is minimal, and 
support earlier findings suggesting that 
salivary acetaldehyde production is mainly 
of bacterial origin in subjects with normal 
ALDH2. 
 
3. The use of gastric proton pump inhibitors 
leads to hypochlorhydria and overgrowth of 
bacteria in the gastric juice. This associates 
with enhanced intragastric production of 
carcinogenic acetaldehyde via ADH 
mediated ethanol oxidation carried out by 
the aerobic bacteria representing normal 
oral microflora. These results indicate for 
the first time that microbial in vivo 
acetaldehyde production from ingested 
ethanol also takes place in the hypo-
chlorhydric stomach. In addition, our 
results suggest that long term use of proton 
pump inhibitors may increase the risk of 
gastric cancer. 
 
4. This study showed that high microbial 
acetaldehyde production from ethanol and 
minor endogenous ethanol and 
acetaldehyde formation from glucose also 
occurs in the stomach of patients with 
achlorhydric atrophic gastritis. Microbial 
analysis revealed that in addition to a vast 
selection of oral bacteria, Entero-
bacteriaceae and yeasts, both known to be 
high acetaldehyde producers, were also 
found in many of the gastric juice samples 
of the atrophic gastritis patients 
participating in the in vivo study. Since 
acetaldehyde is a local carcinogen in the 
digestive tract in humans, intragastric 
production of this compound could be one 
of the factors responsible for enhanced 
gastric cancer risk among patients with 
atrophic gastritis.   
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5. It has previously been demonstrated that 
oral yeasts have a high capacity to produce 
acetaldehyde from ethanol. In this study 
with oral aerobic bacteria isolated from 
hypochlorhydric gastric juices, we showed 
additionally that Neisseria and Rothia 
species and Streptococcus salivarius are 
also very potent acetaldehyde producers 
according to their ADH activities, Km
values for ethanol, and in vitro capacity to 
produce acetaldehyde from ethanol. Since 
Neisseria species and Streptococcus 
salivarius were also among the most 
prevalent and numerous bacteria found in 
the hypochlorhydric gastric juices, it can be 
assumed that these bacteria are also 
responsible for the bulk of the acetaldehyde 
production in the hypochlorhydric stomach. 
Thereby, these findings offer new and  
 
important information with respect to the 
local production of carcinogenic acetalde-
hyde in the upper digestive tract of 
achlorhydric human subjects. 
 
Together with earlier epidemiological data 
and studies in this field, the findings of this 
thesis provide strong evidence for the local 
carcinogenic action of acetaldehyde in the 
upper digestive tract in humans. The 
carcinogenic effects of acetaldehyde can be 
modified by genetic factors, drinking and 
smoking habits, individual differences in 
oral and gastric microflora, and blood and 
intraintestinal ethanol levels. The present 
findings open a new genetic and 
microbiological approach for the 
pathogenesis, screening and prevention of 
digestive tract cancers. 
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